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Abstract
Background and aims: Myotonic dystrophy type 1 (DM1) is an autosomal dominant 
multisystemic disorder, caused by an expanded CTG repeat on chromosome 19. The 
disorder can present both in children and adults. The overall purpose of this study was 
to gain further insight on neuropsychiatric and neurocognitive aspects, vision and mo-
tor function in individuals with congenital and childhood DM1. Further to correlate 
the size of the CTG repeat expansion, inheritance and the onset form with the clinical 
findings.
Methods: Fifty-nine children and adolescents with DM1 were included. Based on 
age at onset and presenting symptoms, the individuals were divided into four groups; 
severe and mild congenital, childhood and classical DM1. In study I and I�, the re-
sults were compared with healthy age and gender-matched controls. Measurement of 
muscle strength, motor function and contractures was performed. According to the 
DSM-I� criteria, neuropsychiatric diagnoses were assigned on the basis of all available 
information. The intellectual level was assessed using the Griffiths Mental Develop-
mental Scale or the Wechsler Scales, and adaptive skills using the �ineland Adaptive 
Behaviour Scales. The ophthalmological examination included best corrected visual 
acuity, refraction, slit-lamp biomicroscopy, indirect ophthalmoscopy and flash visual 
evoked potentials (�EP). 
Results:  Motor function and muscle strength was significantly reduced in children 
with DM1 compared with healthy controls, but there was great variation regarding 
the degree of muscle weakness. Forty-nine percent had an autism spectrum condi-
tion (ASC) and autistic disorder was the most common diagnosis, present in 35% of 
the affected individuals. A large majority of the participants had learning disability, 
usually in the moderate to severe range. Almost all participants showed poor adaptive 
skills. The ophthalmological study shows a higher prevalence of low visual acuity and 
refractive errors compared with the controls. No true cataract was found. Subtle non-
specific fundus changes were present in addition to �EP pathology. The frequency of 
ASC increased with increasing CTG repeat expansions. Motor function, intellectual 
level, visual acuity and adaptive skills presented lower values in individuals with larger 
CTG repeat expansion size. Maternal inheritance had a negative impact on intellectual 
and adaptive functioning. The more severe the form of DM1, the more reduced the 
motor function and visual acuity, and the higher the frequency of ASC and learning 
disability. 
Conclusions: DM1 in childhood shows great variability regarding symptoms and age 
at onset. At the individual level, the size of the CTG repeat expansion cannot predict 
the DM1 form. No clear genotype-phenotype correlations were found, although the 
largest expansions were present in the severe congenital group. In everyday life, it ap-
pears that individuals with DM1 primarily suffer from their CNS-related symptoms, 
such as cognitive deficits, neuropsychiatric problems and visual dysfunctions, rather 
than their neuromuscular symptoms. 
Key words: myotonic dystrophy type 1, children, muscle strength, motor function, autism 
spectrum conditions, learning disability, adaptive skills, visual impairment, hyperopia
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Introduction
Introduction and background
During 1995-1997, the National Swedish Board of Health and Welfare funded a 
survey of children and adolescents with neuromuscular disorders in the western 
health care region of Sweden. The results of the survey showed that more knowledge 
on DM1 in childhood was needed. In parallel with this survey, the dentist Monica 
Engvall had performed studies on adults with DM1, showing impaired orofacial 
function and inadequate dental care. Her studies gave rise to the question of whether 
these problems could be inhibited or delayed during childhood. Our multidisci-
plinary research work was undertaken as an effort to improve the knowledge of 
childhood onset DM1.
To a neuropediatrician working with children with neurodevelopmental disorders, 
DM1 is a most challenging disorder due to the multiorgan involvement, the pro-
gressive course, the affection of various members of the same family and, last but 
not least, the complex pathogenetic mechanisms. The goal of rehabilitation is that 
children and adolescents with impairments should be able to live as independently 
as possible, with the same rights, opportunities, responsibilities and obligations as 
the rest of society. (The Swedish National Board of Health and Welfare. Art. No 
2006-114-24). To optimise the rehabilitation efforts for children and adolescents 
with DM1, specific knowledge on the different aspects of the disorder and their con-
sequences is needed. This thesis focuses on classification and the impact on motor, 
visual and cerebral function in patients with congenital and childhood DM1.
Historical background
DM1 can be traced back as far as the Egyptian pharaoh Akhenaton (1380-1362 
BC), the predecessor of Tutankhamen and the husband of Nefertiti (Albretsen and 
Albretsen, 1999, Cattaino and �icario, 1999). Statues and reliefs of Akhenaton show 
an unhealthy man with elongated face, ptosis, half-open mouth, gynecomastia, 
prominent abdomen and distal limb atrophy, all suggestive of DM1 (Figure 1). The 
similarity in the clinical appearance of the members of this royal family suggests a 
disease with autosomal dominant inheritance that may have caused the end of the 
royal bloodline.
Figure 1  The Egyptian pharaoh Akhenaton (1380-1362 BC)
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Another famous historical person with DM1 (the diagnosis confirmed by DNA 
analysis in a late relative) is the impressionist painter Claude Monet (1840-1926). 
He was diagnosed with cataract in his 60s and had progressive deviant perception of 
colour, shape and perspective maybe as early as from 30 years of age, with wonderful 
consequences for his art (Lane et al., 1997, McLellan, 1996).
DM1 was first delineated as a distinct disorder in 1909 by the reports by Steinert 
(Steinert, 1909) and Batten and Gibb (Batten and Gibb, 1909), although  several 
reports of cases classified as atypical Thomsen s´ disease (atypical mytonia congenita), 
later recognised as DM1, had been published in the literature since the late 19th 
century. During the past 100 years, the knowledge of clinical features, inheritance 
and pathophysiology has increased, although there are still many puzzling issues left 
to be solved, especially in the field of pathophysiology. In addition, the knowledge 
of childhood forms of myotonic dystrophy type 1 (DM1) is more limited than of 
the adult forms.  The congenital form was not  recognised until 1960, when it was 
described in six individuals by �anier (�anier, 1960). Another study presented chil-
dren with DM1 but without congenital presentation (O’Brien and Harper, 1984); 
however, the accepted classification of the childhood form was first stated by Koch 
and co-workers (Koch et al., 1991). 
The autosomal dominant inheritance of the disorder was recognised early. There 
may be a variation in the clinical expression of the disease with exclusively cataracts, 
to the fully developed neurological disorder in the same family. This observation 
made the German ophthalmologist Fleischer introduce the concept of anticipation 
(Fleischer, 1918). The specific phenomenon of anticipation was finally confirmed by 
Höweler (Höweler et al., 1989) and is defined as progressively earlier onset of the 
disease with increasing severity in successive generations within the same family.
When the molecular basis for the disorder was identified in 1992, the phenomenon 
of anticipation was elucidated (Aslanidis et al., 1992, Brook et al., 1992, Buxton et 
al., 1992, Fu et al., 1992, Harley et al., 1992, Mahadevan et al., 1992). The mutation 
responsible for DM1 is caused by an expansion of a DNA sequence, the trinucle-
otide CTG, in the gene coding for the enzyme myotonic dystrophy protein kinase 
(DMPK) on chromosome 19. The situation was complicated by the identification in 
1994 of a second multisystemic disorder similar to this classic form of myotonic dys-
trophy, but without a CTG expansion (Ricker et al., 1994, Thornton et al., 1994a). 
This syndrome was initially referred to as proximal myotonic myopathy (PROMM) 
or proximal myotonic dystrophy (PDM), but the nomenclature was changed to 
DM2 in 1999. The mutation responsible for DM2 is a CCTG repeat expansion in 
the first intron of zinc finger protein 9 (ZNF9) on chromosome 3q21 (Liquori et al., 
2001, Ranum et al., 1998, Ricker et al., 1999). DM1 and DM2 show similarities 
with regard to the clinical phenotype with some exceptions; no congenital presenta-
tion or mental retardation has been described in DM2. How mutations in two unre-
lated genes in different parts of the genome could give similar multisystemic features 
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was a puzzling phenomenon until the “gain of function” RNA mechanism as the 
common denominator in both types of myotonic dystrophy was found (Liquori et 
al., 2001, Ranum and Day, 2004).
Pathogenesis
DM1 is caused by an expanded CTG trinucleotide repeat located in a 3´ intron,; i.e., 
in an untranslated region of the DMPK gene on chromosome 19 (19q13.3) No other 
mutations are found and DM1 was the first dominantly inherited disease found to 
be caused by an untranslated repeat expansion (Brook et al., 1992, Fu et al., 1992). 
Unaffected individuals have approximately 5-35 CTG repeats and expansions greater 
than approximately 55 copies are associated with the disease. The CTG expansions 
are highly unstable in the germ-line and most intergenerational transmissions result 
in a progressive increase in the repeat length in successive generations (i.e., anticipa-
tion) (Harper et al., 1992). The repeat length varies from 50 in the mild form to sev-
eral thousands in the congenital form, the latter inherited maternally in most cases 
(Zeesman et al., 2002). The number of CTG repeats is broadly correlated with age 
at onset and severity of the disorder, but caution is warranted in predicting disease 
severity on the basis of the CTG repeat number in separate individuals (Marchini et 
al., 2000, Salehi et al., 2007). In addition to the germ-line instability, the triplet re-
peat expansion shows somatic mosaicism, implying genetic instability with variable 
repeat size in different tissues of affected individuals, as well as increasing expansion 
length with increasing age (Jansen et al., 1994, Thornton et al., 1994b).
Three distinct models have been put forward to explain how a triplet repeat expan-
sion in a non-coding region of a gene could cause DM1: 1) haploinsufficiency of 
DMPK, 2) altered expression of neighbouring genes and 3) RNA toxicity (Figure 
2). The DM1 models reveal a complex picture where the three separate mechanisms 
appear to contribute simultaneously to the onset of each particular DM1 clinical 
feature (Kaliman and Llagostera, 2008). 
1) Haploinsufficiency is defined as the occurrence of only a single functional copy 
of a gene with the other copy inactivated by mutation. The single functional copy of 
the gene does not produce enough of the gene product; a protein. In DM1, the CTG 
expansion is transcribed into mRNA containing CUG expansions and the level of 
DMPK mRNA is not decreased (Krahe et al., 1995), but the mRNAs are retained 
in nuclear foci inhibiting nucleocytoplasmatic transport (Davis et al., 1997, Taneja 
et al., 1995). Subsequently, there is a decrease in the translation to DMPK protein in 
the cytoplasm (Furling et al., 2003, Furling et al., 2001b). Haploinsufficiency may 
contribute to the DM1 phenotype especially in skeletal and cardiac muscles but does 
not account for all the clinical features of the disease (Jansen et al., 1996, Reddy et 
al., 1996).
2) The expanded CTG mutation may cause chromatin condensation and alter the 
transcription of either one of three genes in the DM1 locus: the DMPK itself, the 
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adjacent upstream DMWD (dystrophia myotonica-containing WD repeat motif) 
and the downstream SIX5 (formerly DMAHP) genes (Frisch et al., 2001, Klesert 
et al., 1997, Otten and Tapscott, 1995, Thornton et al., 1997). SIX5 mRNAs are 
expressed in tissues such as skeletal muscle, the heart, eye and brain. The DMWD 
is expressed in the brain and testes. Like the first model, this second model explains 
some but not all the clinical features of the disease.
3) RNA toxicity is considered the main pathogenic process in DM1. The CTG ex-
pansion is transcribed into mRNA containing CUG expansions and retained in nu-
clear foci (Davis et al., 1997, Taneja et al., 1995). The longer the CUG repeat expan-
sion, the more likely it is that formation of highly stable hairpins occurs (Napierala 
and Krzyzosiak, 1997). Shorter expansions form single strands of CUG repeats. The 
mutant RNA disrupts the regulation of alternate splicing of mRNA (Mankodi et al., 
2000, Tapscott, 2000). RNA splicing is the process in which introns are removed 
from pre-mRNA, the primary transcript, and exons are joined together. Selection 
of which exons to include in the mature mRNA makes the process flexible and a 
single gene can produce multiple mRNA. The splicing process is firmly regulated 
by regulatory proteins. Changes in the concentration of these regulatory proteins 
influence the frequency of inclusion or skipping of a particular exon (Black, 2003). 
Essential to the pathogenesis of spliceopathy in DM1 is that developmentally regu-
lated splicing events fail to switch from an embryonic to an adult splicing pattern, 
resulting in aberrant expression of embryonic isoforms that are unable to support the 
functional requirement of adult tissue. The splicing of the pre-mRNA is controlled 
by splicing of regulatory proteins from two antagonistic factor families, the muscle 
blind-like (MBNL) and the CUGBP1/ETR-3-like factors (CELF) (Ho et al., 2004, 
Kanadia et al., 2003, Philips et al., 1998, Timchenko et al., 1996a, Timchenko et 
al., 1996b).
Th e muscle blind-like (MBNL) family binds to large CUG expansions (Kino et al., 
2004, Miller et al., 2000) and are sequestered in DM1 skeletal muscle and neuronal 
ribonuclear foci (Jiang et al., 2004, Mankodi et al., 2003, Mankodi et al., 2001). The 
other splicing regulatory protein, the CUG-BP1, binds to the single-stranded CUG 
expansions which remain soluble in the nucleoplasm and, unlike MBLN, CUG-
BP1 does not co-localise with nuclear foci (Fardaei et al., 2001, Jiang et al., 2004, 
Junghans, 2009, Mankodi et al., 2003). The binding of MBLN and CUG-BP1 to 
the CUG expansion  causes a downregulation of the former and upregulation of the 
latter protein with improper splicing of pre-mRNA as a consequence (Timchenko 
et al., 2001).
Transcripts with less expanded repeat show less nuclear retention, indicating that the 
length of the CUG repeats determines nuclear foci formation (Davis et al., 1997). 
Mutant DMPK transcripts containing expanded CUG repeats are detected as large 
nuclear foci as well as multiple complexes of smaller sizes found throughout the 
cytoplasm and in nuclei. Two stages of DM1 development have been suggested 
(Mahadevan et al., 2006)  (Dansithong et al., 2008, Junghans, 2009, Timchenko, 
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2006). In the first stage, MNBL binds to pathogenic CUG repeats and reduces their 
toxicity, representing a protective mechanism. When a significant portion of MBNL 
is recruited into foci, CUG repeats bind to CUG-BP1, leading to increased CUG-
BP1 levels and development of DM1 symptoms.  
Figure 2 Model of RNA pathogenesis  
The CTG expansion is transcribed into mutant mRNA which is retained in nuclear foci 
inhibiting nucleocytoplasmatic transport. Alternate splicing of other pre-mRNA´ s and 
the switch from an embryonic to an adult splicing pattern is disrupted. The splicing of 
the pre-mRNA is controlled by the regulatory proteins MBLN and CUGBP. CUGBP 
binds to the single-stranded CUG expansions which remain soluble throughout the cyto-
plasm and in the nuclei. MBLN binds to the double-stranded CUG expansions, forming 
“hairpins” in insoluble nuclear foci. 
In DM1, more than 15 splicing alterations have been found but, most certainly, there 
are many more that have not yet been described (Jiang et al., 2004, Lin et al., 2006, 
Osborne and Thornton, 2006, Ranum and Cooper, 2006). The following genes 
have been found with altered splicing in skeletal and cardiac muscles: cardiac tro-
ponin T (TNNT2), insulin receptor (IR), muscle-specific chloride channel (ClC-1), 
myotubularin-related protein 1 (MTMR1), fast skeletal troponin T (TNNT3), ry-
anodine receptor (RyR), and sarcoplasmic/endoplasmic reticulum Ca2+ ATPase 2 
(SERCA2). Misregulated alternative splicing of the Tau, NMDAR1 (N-methyl-D-
aspartate receptor 1) and APP (Amyloid Precursor Protein) has been described in the 
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brain. Additional molecular mechanisms influence the DM1 phenotype. Aberrant 
methylation at the DM1 locus, as well as increased levels of mutant transcripts in 
skeletal muscles, occurs only in congenital DM1 (Filippova et al., 2001, Steinbach 
et al., 1998).
Epidemiology
The DM1 mutation worldwide is supposed to originate from one or a few ances-
tors, as all disease chromosomes include the same insertion allele in intron 8 of the 
DMPK gene (Neville et al., 1994). The mutation occurred in human history recently 
after a population had moved out of Africa. The disorder is practically absent in 
southern and central Africa, less prevalent in Southeast Asia, and more common 
in western Europe, Japan, USA and Canada (Emery, 1991). Due to the founder ef-
fect; i.e., the loss of genetic variation when a new colony is formed by a very small 
number of individuals from a larger population, the prevalence reported varies be-
tween different populations with remarkably high numbers from specific regions, 
such as Norrbotten, Sweden, in the 1960s, where the prevalence was reported to be 
36.5/100 000 (Rolander and Floderas, 1961) or Quebec, Canada, with a prevalence 
of 189/100 000 (Mathieu et al., 1990), in contrast to the worldwide prevalence of 
approximately 1-10/100 000. Few epidemiological studies have been carried out on 
childhood onset DM1, but a prevalence of 5/100 000 has been reported (Darin and 
Tulinius, 2000). In the same study, birth incidence of congenital DM1 was 5.2/100 000 
and 6/100 000 has been reported in Great Britain (O’Brien and Harper, 1984). In-
dividuals with congenital DM1 contribute more to incidence than prevalence, due 
to the increased mortality during the neonatal period. The frequency of childhood 
DM1 is most certainly underestimated. In families with DM1, the mutation will 
gradually be lost, as individuals with congenital DM1 do not give birth to children. 
Within the normal population, there will be individuals with slightly expanded 
CTG repeat sizes (20-35 repeats) and due to anticipation, the repeat expansion will 
gradually increase on transmission giving rise to new families with the disorder. The 
disorder may be discovered for the first time in a family when a previously undiag-
nosed mother gives birth to a child with congenital DM1.
Clinical features
The term myotonic dystrophy is in itself disputable. The myotonia in DM1, at least 
in the congenital and childhood forms, is not a prominent feature, compared with 
the other ion channelopathies such as myotonia congenita or Scwartz-Jampel syn-
drome. Furthermore, to classify DM1 as a muscular dystrophy is not warranted as 
dystrophic features are not the major finding in the phenotype. It would be more 
reasonable to describe and classify DM1 amongst the trinucleotide repeat disorders.
DM1 can be divided into four main categories, each presenting specific clinical fea-
tures and management problems: (1) congenital; (2) childhood; (3) classical/ adult 
onset and (4) late onset/asymptomatic (Harper, 2001b, Koch et al., 1991). No abso-
lute distinction exists between these categories, which rather form a continuum (De 
Die-Smulders, 2004).
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Congenital DM1:
Patients with congenital DM1 present in utero with reduced foetal movements 
and polyhydramniosis reflecting reduced foetal respiratory movements and swal-
lowing. Premature delivery is common. In the immediate postnatal period there 
is a variable degree of hypotonia. The most severely affected individuals exhibit 
severe hypotonia, immobility and hyporeflexia, and fail to establish spontane-
ous respiration. Sustained respiratory distress due to intercostal muscle weakness 
and/or pulmonary hypoplasia requires assisted ventilation. On X-ray there will 
be signs of thin ribs and raised right hemidiaphragm. Most children survive 
nowadays with modern neonatal care and, in most cases, the respiratory prob-
lems decrease as the child grows older (Campbell et al., 2004). The duration 
of mechanical ventilation has been regarded as guidance for the prognosis (see 
below).
Furthermore, the neonate demonstrates a characteristic facial weakness (facial 
diplegia) with tented upper lip and mild ptosis. Weakness is also present in the 
jaw and palate, resulting in poor sucking and swallowing. Due to slow gas-
trointestinal motility together with respiratory distress and risk of aspiration, 
nasogastric tube feeding is required in many children. Congenital hip luxation 
and flexion contractures may be present with talipes equinovarus or, with severe 
presentations, arthrogryposis multiplex congenita involving several large joints. 
Other features, such as atrial septal defect (ASD) and patent ductus arteriosus 
(PDA), hematomas of the skin, oedema, undescended testes, inguinal hernias, 
raised head circumference with ventriculomegaly and sometimes even obstruc-
tive hydrocephalus requiring shunt operation, have also been described. Perinatal 
Figure 3 Boy with severe congenital DM1 in the neonatal period and at 5 years of age
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complications are most likely the cause of the obstructive hydrocephalus. 
Most individuals survive the neonatal period and the hypotonia improves gradually. 
Subsequently, after achieving motor functions and muscle strength during child-
hood and early adolescence, motor function will deteriorate. Myotonia is seldom 
present before school age. Scoliosis and contractures may occur and eventually re-
quire orthopaedic surgery. Multisystemic features similar to the adult form such as 
cardiac and gastrointestinal abnormalities arise in late childhood or adolescence. In 
parallel with delayed motor development, learning disability (LD) becomes obvious 
and the vast majority requires special schools for pupils with LD.
Childhood DM1:
In contrast to the congenital form, childhood DM1 is characterised by an unevent-
ful pre- and postnatal history and a normal development during the first year of life. 
Symptoms present between one and ten years of age with increasing problems such 
as failure to thrive accompanied by abdominal symptoms, variable degree of LDs 
and muscle hypotonia including clumsiness (de Die-Smulders, 2000, Koch et al., 
1991). Weak facial expression is present, but without the characteristic tented upper-
lip appearance of the congenital form. Indistinct speech is common and some have 
swallowing problems. School difficulties during the early years may be present, and 
language delay and/or school difficulties are sometimes the cause of the first medical 
consultation (Echenne et al., 2008).
Presentation with early cardiac involvement with conduction abnormalities from 
approximately 10 years of age may occur (Bassez et al., 2004). Annual electrocar-
diograms should therefore be included in the routine management. In adolescence, 
myotonia is frequently present and symptoms of distal muscular weakness may 
evolve. In the second decade of life, individuals with childhood onset DM1 show 
many of the symptoms seen in the adult onset form.
Figure 4 Boy with childhood DM1 and his mother with classical DM1
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Classical/adult onset DM1:
Classical DM1 is the most common category of DM1 with début of symptoms in 
adolescence or early adult life. The core symptoms are characteristic muscle involve-
ment with facial weakness, ptosis, distal weakness and myotonia. The initial pres-
entation could relate to other organs rather than to muscle weakness or myotonia. 
Such atypical presentations include cardiac rhythm abnormalities, excessive daytime 
sleepiness, irritable bowel syndrome, premature balding in males and, for women, 
the birth of a congenitally affected child. There is an insidious progression of the 
muscle weakness and many become severely disabled by the fifth and sixth decades. 
Respiratory insufficiency due to weakness of the diaphragm and respiratory muscles, 
aggravated or precipitated by aspiration and chest infections, are common. Sudden 
death is probably attributable to cardiac rhythm disorders and is not entirely pre-
ventable by pacemaker insertion.
Late onset/asymptomatic DM1:
Late onset DM1 presents with cataract in middle or older age but only rarely with 
signs of muscle weakness or myotonia. Besides mild verbal memory dysfunction no 
major cognitive impairment is detected (Modoni et al., 2004). The main reason for 
identifying a transmitting grandparent, with respect to genetic counselling, is to 
identify other affected family members, as the individuals themselves will not likely 
develop any significant complications of DM1 other than cataract.
Muscle involvement in DM1
Skeletal myogenesis is a firmly regulated developmental programme that directs mus-
cle precursor cells (myoblasts) to differentiate into muscle fibres. This process occurs 
in adults to replace lost muscles fibres as well in the embryo to produce muscles fibres 
in the first place. Fibres mature into several different types and exhibit plasticity as 
muscle fibers can adapt to changing demands by changing their size or fibre type 
composition (Scott et al., 2001).  The satellite cells in muscles are the tissue-specific 
muscle stem cells. These cells are activated by muscle stress or damage to form new 
myotubes that are incorporated into the damaged myofibers (Seale and Rudnicki, 
2000). The abnormal retention of mutant RNA in nuclear foci in myoblasts and 
myotubes in congenital DM1 muscle cells may modify the myogenic programme, 
as a reduction in the proliferative capacity of cultured congenital DM1 myoblasts 
is accompanied by a decrease in the number of satellite cells (Furling et al., 2001a). 
Modification on the myogenic programme could also be the consequence of altered 
splicing of Myotubularin-related 1 (MTMR1) mRNA as abnormal MTMR1 tran-
script in differentiated congenital DM1 muscle cells has been demonstrated (Buj-
Bello et al., 2002). Foetal muscle development is affected in the congenital form of 
DM1 with severe hypotonia present from birth. The histopathological features in 
muscle biopsies from neonates with congenital DM1 have revealed small, immature 
muscle fibres and increased numbers of satellite cells (Farkas-Bargeton et al., 1988, 
Sarnat and Silbert, 1976). Normally, the number of satellite cells decreases during 
muscle development as the satellite cells are incorporated into myofibres. 
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The severe hypotonia in the newborns with congenital DM1 causes characteristic 
facial weakness with tented upper lip, ptosis and wasting of temporal muscles. Suck-
ing difficulties due to facial weakness, respiratory distress and dysmotility often re-
quire initial nasogastric tube feeding.  The severe oral motor impairment during the 
neonatal period improves gradually. The speech pathologist in our research team has 
assessed a cohort of individuals with congenital and childhood DM1. All had im-
paired facial expression, moderately or severely reduced intelligibility and, in a ma-
jority of individuals, moderate or severe impairment of lip motility, tongue motility 
and lip force. The families reported problems with chewing, swallowing and drool-
ing. Oral motor dysfunction was most prominent in congenital DM1 (Sjogreen et 
al., 2007). Over a period of four years, progression of the orofacial muscle weakness 
was seen in many individuals and often began before puberty (Sjogreen et al., 2008). 
Swallowing problems as well as mild facial weakness were also reported in childhood 
DM1 by other researchers (De Die-Smulders, 2004).
As muscle strength gradually improves, most children achieve independent walking 
(Echenne et al., 2008, Roig et al., 1994). In the long run, children will gradually 
develop progressive muscle weakness, but it is still unclear at what age improvement 
in muscle strength turns to deterioration, although Hageman has proposed the age 
around puberty (Hageman et al., 1993).
The pattern of muscle weakness in adults includes facial weakness, ptosis and weak-
ness of the sternocleidomastoid and distal limb muscles (Harper, 2001b). Weakness 
of ankle dorsiflexors causes foot drop. The facial weakness is typical and an early fea-
ture, but rarely noted by the patient. Weakness of neck flexion is also an early sign, 
often noticeable already in childhood (De Die-Smulders, 2004), and patients may 
notice problems with  lifting their head from the pillow or a tendency for the head to 
fall backwards during acceleration of the vehicle in which they are travelling. 
Myotonia; slow relaxation of the muscles after voluntary contraction, is another 
typical feature in patients with DM1. It is the clinical symptom of delayed relaxation 
of the muscle due to repetitive and inappropriate opening of the sodium channels. 
Clinical myotonia is never present in the first year of life, and even electrical myoto-
nia is uncommon, but appears later in childhood.
Muscle pain may be present, but is not a major complaint in childhood, although 
some children may experience pain after excessive exercise. 
Brain lesions in DM1
The normal developmental process of the brain includes formation of the neural 
tube, formation of prosencephalon, neuroepithelial cell proliferation and migration, 
neuroglial differentiation, organisation of the cortical circuit network and finally 
myelination. At what stage of brain development an insult occurs determines the 
outcome of the pathological process (Suzuki, 2007).
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Histopathological studies on cerebral changes in DM1 include findings from only 
a few children, mainly with the congenital form. The data presented vary from a 
normal architecture (Young et al., 1981) to a wide range of abnormalities. Disturbed 
neuronal migration with neurons present in the subcortical white matter, abnormal 
cortical layering, polygyria and leptomeningeal neuroglional heterotopia have been 
described. Other abnormalities such as periventricular leukomalacia, ventriculom-
egaly, olivary dysplasia, small tegmentun, defects of the septum pellucidum, corpus 
callosum hypoplasia as well as hypoxic-ischaemic encephalopathy and basal ganglia 
abnormalities have been reported (Endo et al., 2000, Garcia-Alix et al., 1991, Hage-
man et al., 1993, Rosman and Kakulas, 1966, Sarnat and Silbert, 1976).
Brain imaging studies in children with DM1 have revealed a high prevalence of 
brain abnormalities, such as ventriculomegaly, mild atrophy of the frontal cerebral 
cortex, hypoplasia of the corpus callosum, brainstem hypoplasia, neuronal migratio-
nal disturbances and cerebellar abnormalities (Bergoffen et al., 1994, Di Costanzo 
et al., 2002, Garcia-Alix et al., 1991, Hashimoto et al., 1995, Kuo et al., 2005, Mar-
tinello et al., 1999, Nakagawa et al., 1994, Regev et al., 1987). With rare exceptions, 
all the studies present findings from congenital DM1 and neuroimaging studies on 
large numbers of patients with childhood DM1 are lacking. The ventriculomegaly 
already present at birth points to a prenatal developmental origin (Kuo et al., 2005). 
Obstructive hydrocephalus has been reported in rare cases (Rettwitz-�olk et al., 
2001, Rutherford et al., 1989). Another recurring finding of hyperintensity of the 
white matter is shown in several studies (Di Costanzo et al., 2002, Hashimoto et al., 
1995, Kuo et al., 2005, Tanabe et al., 1992). The origin of these often periventricular 
white matter lesions is unclear. One explanation may be delayed myelination, an-
other perinatal asphyxia  (Tanabe et al., 1992). 
Although CNS abnormalities have been shown in childhood-onset DM1, the con-
nection to the pathogenic mechanisms remains unclear. The early presence of mu-
tant transcripts may alter the expression of genes regulating later stages of brain 
development (Modoni et al., 2004). This hypothesis is supported by the fact that the 
expression of the DMWD protein in mice increases during the early neonatal stages 
in neurons localised in central nervous system areas with a high density of synaptic 
connections (Westerlaken et al., 2003). If expression of the DMWD protein is de-
creased in DM1, the formation of neuronal networks will be compromised.
Splicing of tau is tissue and cell-specific and is highly regulated during development 
and cell differentiation. Splicing alterations of tau pre-mRNA with reduced expres-
sion of exons 2, 3, 6 and 10 in DM1 are known so far. Further evidence is needed 
to determine whether DM1 could be regarded as a so-called tauopathy (Leroy et 
al., 2006, Sergeant et al., 2001). Recently published data showed increased levels of 
T-tau in the cerebrospinal fluid in patients with classic DM1 but no correlation with 
CTG repeats was found (Winblad et al., 2008).
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Learning disability 
Learning disability (LD) is characterised by significant limitations in both intellec-
tual functioning and adaptive behaviour. According to the DSM-I�, LD is defined 
as A: Significantly subaverage intellectual functioning: an IQ approximately 70 or 
below on an individually administered IQ test (for infants, a clinical judgement of 
significantly subaverage intellectual functioning); B: Concurrent deficits or impair-
ments in present adaptive functioning (i.e., the person’s effectiveness in meeting the 
standards expected for his or her age by his or her cultural group) in at least two of 
the following areas of communication; self-care, home-living, social/interpersonal 
skills, use of community resources, self-direction, functional academic skills, work, 
leisure, health, and safety; and C: The onset is before 18 years of age (APA, 1994). In 
the thesis, the following definition of intelligence levels was used: Normal IQ >85; 
Borderline IQ: 70-84, Mild LD: 50-69, Moderate LD: 35-49, Severe LD: 20-34 
(APA, 1994).
The prevalence of LD, defined as two standard deviations below the mean, is ap-
proximately 2.5% and 85% of the population with LD is in the mild range (APA, 
1994).
In the US, the widely and long-used term mental retardation is increasingly being 
replaced by intellectual disability. The renaming of the American Association on 
Mental Retardation (AAMR) in 2006 to the American Association on Intellectual 
and Developmental Disabilities—AAIDD, reflects this terminology change (Schal-
ock et al., 2007). In the UK, the term LD is used. 
Neuropsychiatry  
Childhood onset neuropsychiatric disorders (COND) with their onset in infancy or 
early childhood and with significant impairments in social, communicative, cogni-
tive, emotional and behavioural functioning are severe neurodevelopmental disor-
ders. CONDs largely result from complex interactions of genomic vulnerability and 
environmental factors occurring over the course of the development of the brain. 
CONDs include conditions such as autism spectrum conditions (ASC), attention 
deficit/hyperactivity disorder (ADHD) and  tics spectrum disorders (APA, 1994).
Autism was first described by Kanner in 1943 (Kanner, 1943). The core features of 
the concept of autism were delineated in 1979 by Lorna Wing and are referred to as 
the symptom-triad. Impairment in three broad areas are present: reciprocal social in-
teraction and communicative abilities and restricted behaviour and interests (Wing 
and Gould, 1979). These symptoms, which in most individuals persist throughout 
life lead to significant impairment. In recent years, awareness of autism as a broader 
spectrum of conditions has resulted in the introduction of the concept of ASC. 
Conditions included in the spectrum are autistic disorder (AD), Asperger syndrome 
(AS) and autistic-like condition (also known as pervasive developmental disorder 
not otherwise specified (PDD-NOS) and atypical autism). Autistic-like condition 
has no specific operationalised diagnostic criteria or algorithms in the DSM-I�. 
Efforts have been made by researchers to tighten up the definition. With this ap-
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proach, the proposed criteria for autistic-like condition are defined as following: the 
social interaction criterion for AD met plus a total of at least four items, but not the 
full DSM-I� criteria for AD. The strict definition of the condition makes it possible 
to compare data across research groups. With respect to the diagnostic criteria for 
AS, delineated by Gillberg and Gillberg (Gillberg and Gillberg, 1989) and based on 
Asperger’s own descriptions, these are more stricter than the ICD-10 and the DSM-
I� (Leekam et al., 2000, Miller and Ozonoff, 1997) (Table 2).  
The rate of ASC varies from 0.5% to 1.1% (Fombonne, 2005, Gillberg et al., 2006, 
Petersen et al., 2006). The prevalence of ASC in children with LD is reported to be 
higher than in the general population; 20.5% of children with severe LD and 5.3% 
of mild LD (Nordin and Gillberg, 1996). In a review of 32 studies on ASC in 2001, 
Fombonne (Fombonne, 2003) found that 30% of children with AD were in the 
normal intelligence range, 30% had mild to moderate LD and 40% had severe to 
profound LD.
Attention deficit hyperactivity disorder (ADHD) is defined according to the DSM-
I� criteria as mainly inattentive, mainly hyperactive/impulsive, or of combined type 
(APA, 1994). ADHD is most typically identified in children with normal neurode-
velopment. Children with LD may have reduced attention spans, impulse control, 
and activity levels. If these symptoms are inappropriate according to their develop-
mental age, a diagnosis of ADHD can be assigned.
In this thesis, the diagnosis “ADHD” was made in individuals with LD in combina-
tion with clinically significant problems in the area of hyperactivity and/or attention 
combined. It should also be emphasised that attention problems may be present to 
some extent in ASC without justifying a diagnosis of ADHD. The diagnoses of ASC 
and ADHD are not mutually exclusive; both diagnoses may be present in one and 
the same individual at the same time.
Psychiatric disorders, cognition and adaptation in DM1
Children with DM1 and comorbid LD were first described as early as 1948 (Tho-
masen, 1948). In the sixties, Calderon pointed out that DM1 was a neglected cause 
of LD (Calderon, 1966). Several authors have reported LD to be the most important 
feature of congenital DM1 (Hageman et al., 1993, Harper, 2001b, Modoni et al., 
2004, Nicholson et al., 1990, Roig et al., 1994). Johnson and co-workers (Johnson 
et al., 1995) reported on significant differences between congenital DM1 and DM1 
with later onset with respect to intellectual and cognitive functioning, with indi-
viduals with the congenital form being more severely affected. 
Studies on childhood DM1 have demonstrated significantly higher achievement re-
garding verbal IQ than performance IQ (Angeard et al., 2007, Cohen, 2006). In 
childhood DM1, FSIQ can be influenced by inheritance with the most prominent 
deficits in individuals with maternally transmitted disorder. Deficits in attention/ 
executive functions, action planning and organization, visuo-spatial deficit and 
reading impairment have also been reported in childhood DM1 (Angeard et al., 
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A.  A total of six (or more) items from (1), (2), and (3), with at least two from (1),  and 
one each from (2) and (3)
1.  qualitative impairment in social interaction:
a. marked impairments in the use of multiple nonverbal behaviors such as eye-to-
eye gaze, facial expression, body posture, and gestures to regulate social interac-
tion
b. failure to develop peer relationships appropriate to developmental level
c. a lack of spontaneous seeking to share enjoyment, interests, or achievements 
with other people, (e.g., by a lack of showing, bringing, or pointing out objects of 
interest to other people)
d. lack of social or emotional reciprocity
2.  qualitative impairments in communication:
a. delay in, or total lack of the development of spoken language (not accompanied 
by an attempt to compensate through alternative modes of communication such as 
gesture or mime)
b. in individuals with adequate speech, marked impairment in the ability to initiate or 
sustain a conversation with others
c. stereotyped and repetitive use of language or idiosyncratic language
d. lack of varied, spontaneous make-believe play or social imitative play appropriate 
to developmental level
3.  restricted repetitive and stereotyped patterns of behavior, interests and activities:
a. encompassing preoccupation with one or more stereotyped and restricted pat-
terns of interest that is abnormal either in intensity or focus
b. apparently inflexible adherence to specific, nonfunctional routines or rituals
c. stereotyped and repetitive motor mannerisms (e.g hand or finger flapping or twist-
ing, or complex whole-body movements)
d. persistent preoccupation with parts of objects
B. Delays or abnormal functioning in at least one of the following areas, with onset 
prior to age 3 years: (1) social interaction, (2) language as used in social communica-
tion or (3) symbolic or imaginative play
C. The disturbance is not better accounted for by Rett's Disorder or Childhood Disin-
tegrative Disorder
Table 1 Diagnostic criteria for autistic disorder according to the DSM-IV
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Table 2  Diagnostic criteria for Gillberg and Gillberg’s Asperger syndrome
1. Severe impairment in reciprocal social interaction (at least two of the following)
a. inability to interact with peers
b. lack of desire to interact with peers
c. lack of appreciation of social cues
d. socially and emotionally inappropriate behavior
2. All-absorbing narrow interest (at least one of the following)
a. exclusion of other activities
b. repetitive adherence
c. more rote than meaning
3. Imposition of routines and interests (at least one of the following)
a. on self, in aspects of life
b. on others
4. Speech and language problems (at least three of the following)
a. delayed development
b. superficially perfect expressive language
c. formal, pedantic language
d. odd prosody, peculiar voice characteristics
e. impairment of comprehension including misinterpretations of literal/implied 
meanings
5. Non-verbal communication problems (at least one of the following)
a. limited use of gestures
clumsy/gauche body language
b. limited facial expression
c. inappropriate expression
d. peculiar, stiff gaze
6. Motor clumsiness: poor performance on neurodevelopmental examination
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2007, Cohen, 2006). Homogeneously weak subtest results have been found in chil-
dren with congenital DM1 (Echenne et al., 2008).  
Decline on neuropsychological measures in childhood DM1, has been reported in 
some studies (Echenne et al., 2008, Steyaert et al., 1997) but not in others (Tuikka 
et al., 1993). 
Psychiatric disorders, ADHD and anxiety disorders in particular, have been shown 
to be common in both congenital and childhood DM1 (Echenne et al., 2008, Goos-
sens et al., 2000). Behavioural abnormalities, especially within the autism spectrum, 
in children and adolescents with DM1 have been described in sporadic cases (Blon-
dis et al., 1996, Echenne et al., 2008, Paul and Allington-Smith, 1997, Saccomani et 
al., 1992, Steyaert et al., 1997, Yoshimura et al., 1989). Furthermore, the behavioural 
profile has been characterised by marked emotional lability and social withdrawal 
indicating underlying psychopathology (Roig et al., 1994, Thompson et al., 1995).
A high prevalence of day-time sleepiness, fatigue and reduced initiative has been 
reported in childhood DM1 (De Die-Smulders, 2004, Quera Salva et al., 2006). 
Fatigue has been defined as an overwhelming sense of tiredness, lack of energy, and 
feeling of exhaustion and is not explained by  muscle weakness (Kalkman et al., 
2005). Fatigue has been reported in 76% of children and adolescents with DM1, 
while somnolence has been found in 52%. Some patients with DM1 show sleep 
onset REM, similar to that observed in narcolepsy. 
There are no studies with systematic assessments of adaptative behaviour in DM1 
with childhood onset. However, as one researcher stated, “children and their parents 
experience great problems in coping with the combination of learning difficulties, 
chronic fatigue and the somatic complaints. Most children have little contact with 
their peer groups and live socially isolated lives” (De Die-Smulders, 2004). Another 
research group reported that all children with congenital DM1 in their study needed 
special education, and only a few individuals with childhood DM1 were able to 
continue to the college level (Echenne et al., 2008).
Vision
The visual pathways include the optic media, the receptors and ganglion cells of the 
retina, the optic nerve (formed by the axons of the ganglion cells) and the optic tract. 
Further, the axons from the ganglion cells synapse at the lateral geniculate nucleus of 
the thalamus and pass through the optic radiation along the lateral ventricle to the 
termination in the primary visual occipital cortex.
Several modalities compose the visual function, not all of which could be assessed, 
especially not in individuals of low developmental age. �A is the ability to distin-
guish details and shapes of objects and is correlated to the function of the fovea and 
the visual pathways. Proper development of visual acuity depends on normal visual 
input from an early age. Any visual deprivation, such as corneal or lens opacities, 
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uncorrected refractive error or strabismus will usually result in a severe and perma-
nent decrease in visual acuity if not treated early in life. �A develops from birth to 
adolescence and �A of 1.0 is reached by 5-6 years of age (Fern and Manny, 1986, 
Gronlund et al., 2006). Depending on the child’s developmental age and coopera-
tive ability, different methods are used for assessing �A. Recognition of letters or 
symbols of decreasing size (optotypes) are used in school-aged children. For children 
with a chronological or developmental age below three years of age, pictures or grat-
ings to gain the child’s attention (Kay’s pictures or Cardiff cards) are used.
The World Health Organisation (WHO) definition of visual impairment (�I) is 
�A < 0.3. �I could be due to processes in the eye alone (ocular visual impairment) 
and/or pathological processes in the visual pathways. Cerebral visual dysfunction or 
cerebral visual impairment include visual field defects, visual perceptual-cognitive 
impairment and subnormal �A (although some have normal �A). Th e prevalence 
of visual impairment in the Swedish pediatric population is 0.11 % (Blohme and 
Tornqvist, 1997). 
The refraction of the eye depends on the curvature of the cornea, depth of the an-
terior chamber, lens power and axial length. The newborn infant is normally hy-
peropic and astigmatic, and the process towards emmetropia is most pronounced 
during the first years of life (Saunders, 1995). Emmetropia is defined as the state of 
vision where an object at infinity is in sharp focus with the eye lens in a neutral or 
relaxed state. Successive growth of axial length and flattening of the lens facilitate 
emmetropisation as the infant grows older. The process of emmetropisation is not 
fully understood but is at least monitored, in part, by central nervous processes as 
the emmetropisation is dependent on visual feedback (Troilo, 1992). Strabismus and 
impaired fixation are other factors that influence emmetropisation negatively (In-
gram et al., 2003, Whatham and Judge, 2007).
�isual evoked potential (�EP) is an electrophysiologic measurement that provides 
information about afferent input to the visual cortex. Compound neuronal activ-
ity is evoked by a visual stimulus and can be measured electrophysiologically. �EP 
consists of specific and non-specific components representing activation of differ-
ent afferent pathways to the visual cortex; the specific response mediated through 
the primary visual pathway and the non-specific via nuclei in the mesencephalon, 
brainstem and thalamus. An abnormal �EP response reflects abnormality in the 
primary geniculo-cortical pathway or the non-specific pathway. Disorders of the 
cerebral white matter may result in distorted �EP (Kristjansdottir et al., 2002). 
A �EP investigation could be performed either as pattern or flash �EP (Odom et 
al., 2004). The pattern �EP is considered to provide more specific information but 
requires stable fixation. Flash �EP, on the other hand, may be used in individuals 
unable to communicate or cooperate, which is the case in many individuals with 
LD and/or autism.
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Ophthalmological findings in DM1
The prevalence of cataract is an important clinical feature of DM1 (Burian and 
Burns, 1966, Reardon et al., 1993a). The link between cataract alone in previous 
generations with later affected family members and obvious muscle disease was rec-
ognised early (Fleischer, 1918). Ophthalmologists are familiar with the typical find-
ings of a multicoloured iridescence localised in the subcapsular regions of the lens 
and have sometimes been the first to make the diagnosis of DM1 on the basis of 
these typical findings (Burian and Burns, 1966). In childhood, lens opacities are 
infrequently described in the literature, and rarely in individuals below ten years of 
age (Echenne et al., 2008, Harper, 2001a). 
Data on ophthalmological findings in children with DM1 are scarce. Strabismus 
is reported in congenital DM1, but not during the neonatal period (Harper, 1975). 
Short axial length has been reported in one study on children with DM1 (Weiss et 
al., 1989). Another publication presented occurrence of high hyperopia in 86% (on 
average +6.0 D), esotropia in 56% and amblyopia in 22% (Bollinger et al., 2008). 
According to the authors, an increased prevalence of hyperopia may be related to 
low intraocular pressure (IOP). This assumption was based on the knowledge of low 
IOP being present in adults with DM1 (Burian and Burns, 1966). The mechanism 
responsible for the development of low IOP is still unclear, but it could be due to in-
creased uveoscleral outflow or aqueous secretion (Khan and Brubaker, 1993), but is 
not related to increased corneal thickness (Rosa et al., 2008). Low IOP may result in 
a mildly microphthalmic state and hyperopic refractive error (Bollinger et al., 2008). 
The degree of hyperopia may roughly be correlated with the CTG repeat expansion 
size, but other factors contribute as well (Bollinger et al., 2008).
Prognosis
The prognosis and progression of the disease is most likely associated with the dis-
ease type and age at onset. In patients with childhood onset, and especially congeni-
tal DM1, the prognosis with regard to work and normal family life is poor (O’Brien 
and Harper, 1984).
In congenital DM1, the mortality is higher, both during the neonatal period and in 
later life. The duration of initial ventilation assistance during the neonatal period is 
supportive in predicting the outcome. A 100% mortality rate before 15 months of 
age has been reported for children ventilated more than 30 days (Rutherford et al., 
1989). A more recent study has shown a more optimistic picture, with 25% mortal-
ity in the first year in children ventilated > 30 days, but developmental delay and 
morbidity were more obvious in this group than in children ventilated less than 30 
days, where no mortality was observed during the first year of life (Campbell et al., 
2004). Adults with congenital DM1 have reduced survival by 50% beyond their 
mid-30s (Reardon et al., 1993b). Life expectancy is greatly reduced in DM1 patients 
compared with the healthy population. Patients with DM1, including adolescents, 
are at particular risk of sudden cardiac death (Bassez et al., 2004) In adulthood, 
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severe abnormality on ECG and a diagnosis of atrial tachyarrhythmia predict sud-
den death (Groh et al., 2008). In retrospective studies, the mortality was 5.3-7.3 
times higher than expected (Mathieu et al., 1999, Mladenovic et al., 2006). Exces-
sive mortality is mainly related to respiratory diseases, cardiovascular complications, 
and malignancies. Lower age at onset is a significant unfavourable prognostic factor 
(Mladenovic et al., 2006).
Therapy
�arious supportive treatments are available. Modafinil is considered to improve ex-
cessive daytime somnolence and is widely used in DM1 (MacDonald et al., 2002, 
Talbot et al., 2003). According to a Cochrane report, more randomised trials are 
needed to evaluate the efficacy and safety of psychostimulants (Annane et al., 2002). 
Somnolence and fatigue are also reported in children and adolescents with DM1 
(Quera Salva et al., 2006), but no trials with modafinil have been performed. An-
other putative pharmacological option for treating somnolence are stimulants such 
as metylphenidate (Peterson and Husain, 2008), well established in the treatment of 
ADHD. Increases in heart rate and systolic and diastolic blood pressure are possible 
cardiac side effects, but have been thought to be clinically insignificant for most chil-
dren with ADHD. Children and adolescents with DM1 could be a special risk cat-
egory, and thorough follow-up is required if treatment with stimulants is initiated.
So far, there is no cure for DM1. Current supportive treatment does not influence 
the disease progression. However, understanding the molecular pathogenesis makes 
it possible to develop molecularly based treatments that target the RNA disease 
mechanism directly, thereby making it possible to reverse the disease phenotype 
(Wheeler, 2008). 
DM1 in the western and southern health care regions of Sweden
The study was performed as a part of a multidisciplinary study of children and ado-
lescents with DM1 at the University of Gothenburg, Sweden (Aring et al., 2009, 
Engvall et al., 2008, Engvall et al., 2007, Sjogreen et al., 2007, Sjogreen et al., 2008). 
In addition, studies on adult onset DM1 have been performed in Gothenburg with 
the focus on cerebral involvement (Winblad et al., 2006a, Winblad et al., 2006b, 
Winblad et al., 2005, Winblad et al., 2008).
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Aims of the present thesis 
The overall purpose of the study was to gain further insight into congenital and 
childhood DM1 regarding neuropsychiatric and neurocognitive aspects, vision 
and motor function.
The specific aims were:
To classify a group of children and adolescents with DM1 into congenital and 
childhood onset forms and to estimate the size of the CTG repeat expansion;
To investigate range of motion, muscle strength and motor function in congeni-
tal and childhood DM1 and to compare muscle strength and motor function 
with a matched healthy control group;
To investigate the neuropsychiatric problems in congenital and childhood 
DM1;
To investigate cognition and adaptive skills in congenital and childhood DM1;
To investigate visual function in a group of individuals with congenital and 
childhood DM1, and to compare the results for visual acuity, significant refrac-
tive errors and electrophysiological findings with groups of matched controls;
To correlate the size of the CTG- repeat expansion, inheritance and onset form 
to motor function, neuropsychiatric findings, cognitive and adaptive skills and 
visual function.
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Methods
Study population
The study population is described in Figure 5. Between January 1999 and December 
2003, 64 children and adolescents with a DNA-confirmed diagnosis of DM1 before 
18 years of age living in the western and southern health care regions of Sweden 
were through their pediatric rehabilitation centers invited to participate. Fifty-nine 
individuals accepted to participate in this study. All individuals were below 18 years 
of age when included in the study for the first time. As some of the individuals were 
almost 18 years of age when included in study I, they were older than 18 when par-
ticipating in study II, III and I�.
Figure 5  Recruitment of the study population
Abbreviation: M:Male, F:Female, y:years
Thirty-four individuals participated in all four studies, and an additional 20 patients 
took part in three of the four studies.
Procedure
A thorough medical history was taken for all the patients, according to a systemati-
cally applied protocol. A clinical neurological examination was performed, and all 
the medical records were reviewed. All children were videotaped during neurologi-
cal and motor examinations.
64 individuals 
with DM1
between 1999-2003
42; 18F (0.8-17.7y),
24M (0.8-17.0y) participated
57; 26F (3.3-21.1y),
31M (2.5-21.3y) participated
49; 20F (7.3-21.4y),
29M (1.6-21.9y) participated
55; 24F (3.4-21.1y),
31M (2.6-21.3y) participated
8 did not particpate
in the study
5 did not 
participate
3 accepted to
participate
41 accepted to
participate
1 did not
participate
14 were
diagnosed after
study I
13 accepted to
participate
1 did not
participate
2 participated, 
data excluded
47 accepted to
participate
1 accepted to
participate
STUDY III
STUDY II
STUDY I
STUDY IV
50 were invited to participate in study I
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Classification
A new classification for congenital DM1 was introduced: All children with con-
genital DM1 have symptoms present in utero (polyhydramniosis and reduced foe-
tal movements) or from birth (respiratory insufficiency, sucking difficulties, facial 
diplegia, hypotonia and/or multiple congenital contractures). Congenital DM1 is 
divided into a severe and a mild form. The difference between the two groups is that 
the former is characterised by a life-threatening condition at birth with need for 
resuscitation and/or respiratory assistance. 
According to age at onset and presenting clinical symptoms, the children were di-
vided into four groups; severe congenital (n=20) and mild congenital DM1 (n=18), 
childhood DM1 (n=19) and classical DM1 (n=2).
Analysis of the CTG repeat expansion size in the DMPK gene
All patients had a confirmed diagnosis of DM1 with CTG repeats > 40. Except 
for the two adopted children, the CTG repeat expansion size was estimated in the 
transmitting parent. DNA was extracted from peripheral blood using a Puregene 
DNA Isolation Kit (Gentra Systems, Minnesota, Minneapolis, USA) and digested 
with restriction endonucleases EcoR1 and Pst1. Fragments were separated on a 0.8% 
agarose gel and subjected to Southern blotting using the pM10M-6 probe (Brook 
et al., 1992). Because of deletion/insertion polymorphism, EcoR1 blots show alleles 
of 9 or 10 kilobases (kb) in normal individuals, whereas Pst1 blots show fragments 
of approximately 1.2 kb. CTG expansions in patients were estimated relative to a 
size marker from the Pst1 blots. As most patients show a smear rather than a distinct 
band, because of somatic mosaicism, the approximate midpoint of the smear was 
reported.
Study I
Forty-two children and adolescents participated, 18 females (0.8 - 17.7 years) and 
24 males (0.8 – 17.0 years); severe congenital DM1 (n=13), mild congenital DM1 
(n=15) and childhood DM1 (n=14). A control group of 42 healthy children was 
matched by gender and age. Gross motor function was assessed by the same physi-
otherapist in all patients.
Measurement of isometric muscle strength
Isometric muscle strength was measured with a hand-held dynamometer (Penny 
and Giles, Chicester, Dorset, Hants, UK) by one and the same physiotherapist in 
all children. Ten muscle groups in the upper and lower extremities were measured 
in a standardised way, and the values obtained were compared with reference values 
from age and gender-matched controls. The best of three values obtained on the 
non-dominant side was compared with values obtained by a matched control sub-
ject. To enable a comparison between the groups of DM1, regardless of the age of the 
children, a quotient was calculated between the isometric muscle strength obtained 
by the child with DM1 and the matched control subject.
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Measurement of myotonia
Myotonia was tested by percussion of the thenar muscle and the tongue, or revealed 
as a delayed ability to relax the grip after forceful contraction of the hand.
Measurement of range of motion (ROM) and skeletal deformities
ROM was measured with a goniometer and photographs of skeletal deformities were 
taken at the time of investigation. A review of medical records and interviews with 
the parents provided information on contractures and skeletal deformities at birth.
Measurement of motor function and walking ability
Motor function was assessed using the Hammersmith motor ability scale (HMA) 
(Scott et al., 1982) (Table 3). The performance is scored on a three-point scale: 0 
(unable), 1 (needs self-reinforcement), and 2 (succeeds). The maximum score is 40. 
Children less than six years old were excluded, as performance on this motor assess-
ment test has been shown to be age-related. The age when the children began to walk 
was noted as well as the children’s walking ability at the time of investigation.
Table 3 The Hammersmith motor ability scale
Study II-III
Fifty-seven children and adolescents participated, 26 females (3.3 -21.1 years) and 
31 males (2.5 – 21.3 years); severe congenital (n=19), mild congenital (n=18), child-
hood (n=18), and classical DM1 (n=2). The children and adolescents were primarily 
assessed by the author and a neuropsychological evaluation was then performed by 
a child psychologist, on average, 0.2 years later (range 0 - 0.8 years). In study II, the 
results from the two individuals with classical DM1 were not presented.
Neuropsychiatric evaluation
One or both parents of all 57 individuals were thoroughly interviewed using struc-
tured interviews regarding neuropsychiatric problems. A clinical neuropsychiatric 
assessment including medical examination and observation of all participants was 
performed.
1.  Lifts head in supine 11.  Standing on toes
2.  Supine to prone over right 12.  Standing on right leg
3.  Supine to prone over left 13.  Standing on left leg
4.  Prone to supine over right 14.  Jumps on right leg
5.  Prone to supine over left 15.  Jumps on left leg
6.  Gets to sitting 16.  Gets of chair
7.  Sitting 17.  Climbing step right leg
8.  Gets to standing 18.  Descending step right leg
9.  Standing 19.  Climbing step left leg
10.  Standing on heels 20.  Descending step left leg
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Autism Diagnostic Interview-Revised (ADI-R)
Autism Diagnostic Interview-Revised (ADI-R) (Lord et al., 1994), a standardised, 
investigator-based semi-structured caregiver interview, was used by a clinical child 
psychologist to interview the parents. According to the ICD-10 (WHO, 1992) and 
the DSM-I� (APA, 1994) the diagnosis of autistic disorder (AD) requires specific 
types of abnormalities in three key areas of functioning: reciprocal social interac-
tion, language and communication, and restricted, repetitive and stereotyped be-
havior, together with evidence of delayed or deviant development in at least one 
of these areas before 36 months of age. The interview contains 84 questions and 
provides separate scores in the distinct areas, as well as early history, with specific 
threshold scores; 10 for reciprocal social interaction, 8 for communication for ver-
bal individuals and 7 for non-verbal,  3 for restricted, repetitive behavior, and 1 for 
deviation in early development. The cut-off scores provide an algorithm where four 
points indicate deficits in all areas and render a diagnosis of AD. The cognitive level 
was taken into account when evaluating the results on ADI-R. ADI-R was used for 
all 57 participants, but as four individuals were at a non-verbal age (younger than 18 
months), results from only 53 individuals are presented.
Questionnaires
Social Communication Questionnaire (SCQ)
The SCQ (previously known as the Autism Screening Questionnaire) is a parent 
questionnaire regarding core diagnostic features of autism (Berument et al., 1999). 
The 40 items are based on the ADI-R, but they have been modified in order to be 
understood by parents without further explanation. There are two versions of the 
SCQ: current and lifetime. The current version is suitable for children younger than 
4 years, while the lifetime version is used with older individuals. This study utilised 
the lifetime version translated into Swedish by Wentz, Råstam and Gillberg 2000.
The Five to Fifteen (FTF)
The FTF is a parent questionnaire for the age group 5-15 years and covers the core 
symptoms of ADHD and related neurodevelopmental disorders (Kadesjo et al., 
2004). The FTF comprises 181 statements and cover eight domains (motor, executive 
functions, perception, memory, language, learning, social and emotional problems). 
Each statement may be endorsed as either “does not apply” (=0), “applies sometimes 
or to some extent” (=1) or “definitely applies” (=2). In addition, there are a number of 
open-ended questions regarding the child’s strengths and weaknesses.
In most cases, the parents had difficulties completing the questionnaires (SCQ and 
FTF) on their own. For this reason, the author used the questionnaires in the inter-
views with the parents.
Neuropsychiatric diagnostic procedure
The diagnostic procedure of COND involves clinical evaluation, systematic inter-
views and instruments. The videotapes recorded during motor and neurological ex-
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amination were analysed retrospectively by the author and two co-authors; a child 
psychologist and a child psychiatrist. On the basis of all the available information, 
neuropsychiatric diagnoses were assigned conjointly by the author and co-authors 
using specific symptom checklists regarding COND (ASC, ADHD and TD), ac-
cording to the operationalised diagnostic criteria of the DSM-I� (APA, 1994). With 
respect to other psychiatric disorders, diagnoses were also assigned according to the 
DSM-I�.
Regarding autistic-like condition (ALC), we used the criteria presented in the intro-
duction. As motor clumsiness and limited facial expressions are both symptoms of 
Asperger syndrome and DM1, both the Gillberg and Gillberg (Gillberg and Gill-
berg, 1989) and the DSM-I� (APA, 1994) criteria had to be met.
Global cognitive assessment
Psychometric assessment of general intellectual ability was performed, and the meth-
ods used were based on developmental age and functioning rather than chrono-
logical age. The three Wechsler scales (WPPSI-R, WISC-III and WAIS-III) provide 
measures of global intellectual ability – the full scale IQ (FSIQ) and the subscores 
of verbal and performance IQ (�IQ; PIQ). Furthermore, the WISC-III and the 
WAIS-III provide subtests and the results are given as raw scores which are trans-
formed into scale scores (1-19, mean 10 [SD 3]) for comparison with age-related 
normative data.
Behavioral observation of all participants was performed during the neuropsycho-
logical examination. The observation covered aspects of attention, activity level, 
impulse control, social interaction, cooperation, emotional state, speech and lan-
guage.
The following definition of intelligence levels was used: Normal IQ >85; Borderline 
IQ: 70-84, Mild LD: 50-69, Moderate LD: 35-49, Severe LD: 20-34 (APA, 1994).
Forty-six of the 55 individuals were assessed by the child psychologist in our research 
team. In four cases, other neuropsychologists had recently assessed the individuals 
and those results were collected (in one case, only four subtests of the WAIS-III 
were assessed). Five children did not complete any tests (three individuals exhibited 
a very low level of functioning; one individual was too tired, and one individual had 
recently had a concussion of the brain). Two individuals were left-handed.
For the assessment of children at a developmental age below 3 years, the Griffiths 
Developmental Scale (Griffiths, 1970) was used (n=8), and the developmental quo-
tients (DQ) obtained were converted to IQ equivalents. The results were compared 
with mean scores on the �ineland Adaptive Behaviour Scales (�ABS) (Sparrow et 
al., 1984). When the developmental age was between 3 and 7 years, the Wechsler 
Primary and Preschool Scale of Intelligence (WPPSI-R) (Wechsler, 1999) was ap-
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plied (n=15). In school-age children (n=23), the Wechsler Intelligence Scale for chil-
dren (WISC-III) (Wechsler, 1992) was used. At age 16 years and older, the Wechsler 
Adult Intelligence Scale (WAIS-III) (Wechsler, 2002) was administered (n=2). 
Adaptive assessment
Adaptive functioning was assessed by interviewing caregivers of all 55 children us-
ing the �ineland Adaptive Behaviour Scales (�ABS) (Survey Form). The �ABS are 
an informant-based measure of adaptive behaviour with four domains and several 
subdomains (within brackets) assessed: Communication (Receptive, Expressive and 
Written), Daily living skills (Personal, Domestic and Community), Socialisation 
(Interpersonal Relationships, Play and Leisure Time, and Coping Skills), and Motor 
skills (Gross and Fine). The motor domain was excluded, as that scale is not appli-
cable to individuals older than 6 years. Age-equivalent scores for each domain were 
examined (mean 100; SD 15). Each subdomain consists of five descriptive levels: 
high, moderately high, adequate, moderately low and low. No Swedish normative 
data exist; therefore, American norms were used.
Study IV
Forty-nine individuals participated, 20 females (7.3 – 21.4 years) and 29 males (1.6 
– 21.9 years); severe congenital (n=17), mild congenital (n=13) and childhood DM1 
(n=19). Three age and sex-matched control groups of Swedish preschool and school 
children living in Gothenburg were selected from a larger cohort. The results in each 
DM1 subgroup were compared with the results in the control groups matched for 
age and gender    (Gronlund et al., 2006). For the �EP results, a group of 51 healthy 
children aged 1-15 years was used (Kristjansdottir et al., 2002).
Visual acuity
The method of assessment was based on cognitive level and/or ability to participate 
rather than chronological age. Distance visual acuity (�A) was tested binocularly in 
all children with own (if any) correction. If possible, assessment with optotypes, the 
KM-Boks chart, H�OT chart or Kay’s pictures, were made.
The KM-Boks chart, a linear arithmetically based letter-matching chart with seven 
equal readability different letters (C D E F K N �) was used (n=36) (Moutakis et 
al., 2004). The KM chart is designed for a testing distance of 3 m. If an individual 
could not manage to read the KM-Boks chart, the H�OT chart was used instead 
(n=2) (Hedin and Olsson, 1984). For illiterate children measurement of �A with 
the Kay Picture test (n=5) (Kay, 1983), the Cardiff test (n=2) (Adoh et al., 1992), or 
“hundreds and thousands” was performed (n=2) (Richman and Garzia, 1983). Two 
individuals (one with severe congenital, aged 5.8 years, and one with mild congeni-
tal DM1, aged 14.2 years) could not take part in any �A test but could fixate and 
follow a penlight.
�isual impairment (�I) was defined as �A≤0.3 (logMAR ≥0.5) (WHO), subnormal 
�A as �A >0.3 to <0.8 (logMAR 0.5 to >0.1) and normal �A as ≥0.8 (logMAR ≤0.1).
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Cycloplegic refraction
After a single instillation of a mixture of cyclopentolate (85 %) and phenylephrine 
(1.5 %), autorefraction was performed with Topcon A6300 (Topcon Corporation, 
Tokyo, Japan) or Nikon Retinomax (Nikon Corporation, Tokyo, Japan). Significant 
refractive errors in children ≥ four years of age were defined as a spherical equivalent 
(SE) of hyperopia ≥ 2.0 diopters (D) (Mayer et al., 2001), myopia ≥ 0.5 D and astig-
matism ≥ 1.0 D in one or both eyes (Gronlund et al., 2006). In children ≤ four years 
of age, significant refractive errors were defined as hyperopia ≥ 4.5 D, myopia ≥ 5.0 
D and astigmatism ≥ 3.0 D (Ophthalmology, 1993).
Lens and fundus examination
Slit-lamp biomicroscopy and indirect ophthalmoscopy were used for lens evaluation 
and fundus examination.
Visual Evoked Potentials (VEP)
Measurement of �EP was performed in 38 individuals by using Grass equipment 
with a short supramaximal light flash stimulus (<50µs, ~ 0.5J). Equipment of our 
own construction, based on a National Instrumental amplifier, was used, with Lab 
�iew software and a Macintosh G3 or later version. Recordings were performed 
from three positions in a horizontal row at the occipital level (O1, Oz, O2, according 
to the international 10-20 EEG system). The �EP single sweep activity was averaged 
(n=20-40) with a 0.3-250 Hz band pass filter. A 50/60 Hz filter setting was some-
times used when a high background noise was impossible to extinguish by electrode, 
wire and skin manipulation (Sjodell et al., 1996).
�EP was considered pathological if N1 differed >2 SD from that of the control group 
i.e. < 39 ms and > 70 ms, P’/P1 complex > 2 SD i.e. < 62 ms and > 104 ms, or other-
wise altered in the wave form.
For the electro-ophthalmologic assessment, both the methods and the investigator 
were the same in the study and the control group (Kristjansdottir et al., 2002).
Statistical methods
The statistical analyses were performed using Statview 4.02 for Macintosh (I), SPSS 
for Windows 15.0 and SAS 8.2 (II-I�). As normal distribution could not be as-
sumed in combination with small sample sizes, non-parametric tests were used. For 
comparison between two groups, the Mantel-Haenszel Chi2 test was used for or-
dered categorical variables (all studies), Fisher’s exact tests for dichotomous variables 
(II, III, I�), the Mann-Whitney U-test for continuous variables (all studies) and the 
Wilcoxon Signed Ranked Test for paired comparisons (I, III). The Spearman corre-
lation coefficient was calculated for analysis of relationships between two continuous 
variables (all studies). To adjust for gender in the comparison between two groups, 
van Elteren’s test was used for continuous variables ((II, III, I�). The Spearman par-
tial correlation coefficient was calculated to adjust for gender in correlation analysis 
(II, III, I�). All tests were two-tailed and conducted at a 5% significance level. Due 
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to the many significance tests the significance level has been set to 1% for the cor-
relations between verbal and performance subtests and CTG (III). 
Ethics
According to the Declaration of Helsinki, the individuals participated voluntarily 
after verbal and written information and written informed consent was obtained 
from the caregivers. The Human Ethics Committees of the Medical Faculties at 
Göteborg University and Lund University, Sweden, approved the studies.
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Results
Classification and baseline characteristics
Baseline characteristics are given in Table 4. On the basis of the disease classifi -
cation, the children and the adolescents were divided into four subgroups: severe 
congenital (n=20); mild congenital (n=18); childhood (n=19) and classical (n=2). A 
male preponderance (16 out of 20 individuals) was found in the severe congenital 
group, in contrast to an almost even distribution of males and females in the other 
two childhood onset groups. 
Some individuals with childhood DM1, some showed mild symptoms during the 
gestational and neonatal period; two children had had mild excess of amniotic fluid, 
five children had been floppier than healthy children and four children had been 
slow suckers but did not require nasogastric feeding. These children had been diag-
nosed as having the childhood type, as the symptoms could be regarded as mild and 
their overall development during the first year was normal. Unilateral subluxation 
of the hip was found in one patient with childhood DM1 and one of the girls with 
classical DM1 was born with uni lateral pes equino varus adductus, but presented no 
other characteristics of congenital or childhood DM1. Six individuals with severe 
and five with mild congenital DM1 were assessed during the neonatal period with 
either ultrasonography or computer tomography of the brain. One individual had 
obstructive hydrocephalus requiring a shunt operation. Three had ventriculomegaly 
and one had both periventricular leukomalacia and ventriculomegaly. Spasticity was 
found in two children with severe congenital DM1, one of whom had the shunt-
requiring hydrocephalus. Brain imaging was not performed in the other individual 
with spasticity. 
Table 4 Diagnostic criteria for severe and mild congenital, and childhood DM1
Severe congenital Mild congenital Childhood
Pre-/perinatal period Symptoms present Symptoms present Uneventful
Resp. assistance and/
or asphyxia
Respiratory assistance 
required and/or asphyxia
No respiratory assistance 
required, no asphyxia
Not present
Hypotonia Severe Mild Not present
Sucking difficulties Severe, require nasogas-
tric tube feeding
Moderate, may require 
nasogastric tube feeding
Not present
Talipes and/or other 
contractures
Frequently present Frequently present Not present
Developmental delay Present before 1 year 
of age
Present before 1 year 
of age
Present between 
1-10 years of age
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Severe 
cong.DM1 
(n=20)
Mild cong. 
DM1
(n=18)
Childhood 
DM1
(n=19)
Classical 
DM1
(n=2)a
Male 16 (80%) 8 (44%) 9 (47%) 0
Female 4 (20%) 10 (56%) 10 (53%) 2 (100%)
Age at time of study inclusion
Mean (SD) 7.6 (5.3) 7.8 (4.4) 11.1 (4.4) 16.7;17.2
Median (range) 6.5 
(0.8-17.0)
8.8 
(0.8-15.3)
10.9 
(5.1-17.7)
No. of CTG repeats
Mean (SD) 1580(420) 980 (450) 910 (320) 475;625
Median (range) 1590 
(730-2100)
1000 
(130-2100)
930 
(260-1500)
Inheritanceb: Maternal/Paternal 20/0 13/3 14/5 0/2
CTG repeats in aff. mothers
Mean (SD) 770 (420) 540 (430) 620 (350)
Median (range) 650 
(100-1700)
500 
(100-1250)
600 
(70-1250)
affected fathers
Mean (SD) 710 (700) 500 (410) 50; 525
Median (range) 625 
(65-1450)
525 
(65-900)
Myotonia 11 10 12 2
Median (age) 8.6 
(1.3-17.0)
8.5   
(3.6-15.3)
10.6 
(5.2-17.5)
16.2;17.2
Walking ability unsupported 12 17c 19 2
Age of walking: Mean (range) 28 mo. 
(13-54)
21 mo. 
(12-43)
15 mo. 
(11-18)
12 mo.
Cognitive level
NIQ/BIQ/MLD/ModLD/SLD 0/1/2/8/8d 1/2/3/9/3 1/1/7/9/0e 1/1/0/0/0
Somatic compl./symptoms
Abdominal symptoms
Constipation/soiling 9/5 8/6 5/3 No abdom.
symptoms
Abd.pain/diarrhoea/lact.intol. 3/1/0 4/3/1 2/3/2
Inguinal hernia 2 1 1
UVI/bladder dysfunction 2/1 2/1 0/1
Undescended testis 10 (62%) 4 (50%) 1 (11%)
Body weight and length
Body weight/length < 2SD 6/5 0/1                    0 /0              Normal body 
composition
Body weight/length > 2SD                                       0/0                    0/0                    2/0
Table 5  Baseline characteristics in the 59 individuals with DM1
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Severe 
cong.DM1 
(n=20)
Mild cong. 
DM1
(n=18)
Childhood 
DM1
(n=19)
Classical 
DM1
(n=2)a
ENT-problems
Recurrent otitis 12 2 4
Otosalpingitis/hearing loss 5 5 3 1
Transmyringeal drenage 6 5 3
Adenectomi/tonsillectomi 0/0 4/1 4/0
Gestational/neonatal period
Polyhydramniosis 14 5 2 0
Preterm delivery (GA) 11 (34-37) 3 (33-36) 0 0
C.section/ vacuum extraction 14/2 4/3 3/4 0/0
Low Apgar scoref 9 0 0 0
Individuals req. assisted vent. 13 (65%) 0 0 0
Days with assisted ventilation
Mean (SD)
26 (43)
Median (range) 3.5 (0-150) - - -
Sucking diff./req. nasog. tube 20/20 13/7 5/0 0/0
Neonatal hypotonia 19 17 5 0
Birth weight (g)
Mean (SD) 2790 (610) 3170 (690) 3470 (580) 3500; 3640
Median (range) 2800 
(1735- 4000)
3050 
(2090-4400)
3400 
(2040-4250)
SGA: BW ≤ 2SD 3 (15%) 1 (6%) 2 (10%) 0
Neonatal cardiac involv.
pulm.hyper./PDA 3/5 1/1 0/1
No cardiac 
abnormal.
rhythm./conduct./contractility 0/1/1 0/0/0 1/1/0
ASD/VSD/cardiac valve abnorm. 1/1/2 1/0/1 0/0/1
Cong. contract. /skel. def. 15 16 1 1
a the individual values are given regarding CTG repeat expansion size, age and birth weight;   b2 children with mild congenital DM1 were adopted, parental transmission unknown; cno information on cognitive level in 1 individual with childhood DM1; 
d5 individuals had not yet acchived independent walking (age range 0.8-4.4 years). Three individuals 
could walk with aids indoors at age of 10, 10 and 17 years. eone male had not achieved indiependent walking at 0.8 years of age. fLow Apgar score was defined as < 5 at five minutes of age; mo.: months; cong.: congenital; no: number 
of; NIQ: normal IQ; BIQ : borderline IQ; MLD: mild LD; ModLD: moderate LD; SLD: severe LD; GA: 
gestational age; SGA: small for gestational age; BW: birth weight; pulm.hyper.: pulmonal hypertension; 
PDA: persistent ductus arteriosus; rhythm.: cardiac rhythm abnormalities; conduct.: cardiac conduct ab-
normalities; ASD: atrial septal defect;VSD: ventricular septal defect ;abnorm.:abnormalities; congenital 
contract.: congenital contractures.
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Inheritance and molecular data
The participants represented 49 families. In ten children from seven families, the 
disease was paternally transmitted. Six out of these ten children represented three 
sibling pairs with two siblings in each pair. The disease was maternally inherited 
in 47 children from 40 families. Fourteen of the children constituted six affected 
sibling pairs; four siblings in one family, two siblings in each of the others. Two 
children were adopted from other countries and we had no information about the 
biological parents. Both the children had mild congenital DM1.
All individuals in the severe congenital group inherited the disorder from the moth-
er. For paternal inheritance in the different DM1 types, see Table 4. The approxi-
mate CTG repeat expansions in the patients are shown in Figure 4. In 44 out of 57 
children in whom information about the affected biological parent was available, the 
disease was not diagnosed in the parent until after the child was born.
Figure 6  The size of the CTG repeat expansions in the different DM1 forms
Study I
Isometric muscle strength
Due to the high frequency of neuropsychiatric problems and the low cognitive level 
in the group of children with severe congenital DM1, participation in the assess-
ment of muscle strength was difficult and suffi  cient data were not obtained. In ad-
dition, some of the children with mild congenital and childhood DM1 could not 
cooperate due to low developmental age. The children with mild congenital DM1 
were significantly weaker than healthy control subjects in all assessed muscle groups. 
The children with childhood DM1 were significantly weaker in the wrist and ankle 
dorsiflexors, abductors and flexors of the hip, and flexors and extensors of the knee. 
There was, however, great variation regarding the degree of muscle weakness, where 
some of the children with childhood DM1 had normal muscle strength.
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Motor function 
Figure 7 shows the motor function score, with a maximum of 40, against age in 
children with DM1 and controls. The maximum score of 40 was not reached before 
6 years of age in the control children. Motor function score is significantly reduced 
in children with DM1 compared to healthy controls.
Jumping, heel-standing and head-lifting in supine were the most difficult items to 
perform for the children with DM1.
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Figure 7 Motor function score, with a maximum of 40, versus age in healthy control 
subjects  () and children with: a) severe congenital DM1 () (n=13), b) mild congeni-
tal DM1 () (n=15) and c) childhood DM1 () (n=14). Significant difference was found 
between healthy control subjects and children with severe congenital DM (p=0,0015), 
mild congenital DM1 (p=0,0006) and childhood DM1 (p=0,0014).
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Contractures and skeletal deformities
Contractures and skeletal deformities were more frequent at the time of investiga-
tion than at birth, which suggests that especially foot and spine deformities increase 
over time. Foot deformities present at birth did not affect age at independent walk-
ing in any of the congenital subgroups. 
Study II-III 
Neuropsychiatric disorders
Fifty-four percent (n=31) of the children and adolescents with DM1 fulfilled at least 
one neuropsychiatric diagnosis as presented in Figure 6. ASC were present in 49% 
and the single most common diagnosis among the ASC was AD, present in 35% 
(n=20) of the study group. The individuals with ASC mainly had impairment in 
social interaction and communication, according to the DSM-I� criteria, and, to a 
lesser degree, problems in the areas of restricted repetitive and stereotyped patterns 
of behaviour, interests and activities, but enough to fulfill the criteria for ASC. One 
female had Asperger syndrome both according to the Gillberg & Gillberg and the 
DSM-I� criteria. Twelve individuals (22 %) fulfilled the criteria for AD accord-
ing to the ADI-R algorithm. The mean scores of the different subdomains of the 
ADI-R were high in the whole DM1 group. Regarding the “repetitive” behaviour 
subdomain, none of the individuals with ASC exhibited self-injurious behaviour. 
Individuals with ASC did not have significantly lower mean �IQ, PIQ or FSIQ, 
except for the individuals with mild congenital DM1 and ASC, where PIQ was 
significantly lower compared to those without ASC in the same subgroup. ASC was 
not correlated to gender or motor function.
Individuals with ASC and childhood DM1 scored significantly lower on the sub-
domain of Daily living
Figure 8 The childhood onset neuropsychiatric disorders in the study population
Abbreviation: ASC: autism spectrum condition, “ADHD”: attention and hyperactivity 
disorder combined with LD, TD: Tourette´ s disorder
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Qualitative behavioural data 
Most of the participants were kind, passive and had a  low level of activity; more 
individuals tended to be passive, tired and calm rather than active and quick. The 
individuals talked fairly well even though they were withdrawn. They did not use 
language in a socially spontaneous way and they were not good at taking social ini-
tiatives. The symptoms of fatigue and excessive day-time sleepiness were frequently 
reported by the parents, although we lacked instruments to quantify the extent of 
these symptoms. There was no attrition from assessment caused by day-time sleepi-
ness.  
The clinical impression, according to the test results, indicate that their focusing 
skills were poor and they overlooked details, but they were not easily distracted by 
external impulses. In spite of the fact that many of the individuals had ASC, and 
although the Wechsler scales were a challenge to most of the participants, they coop-
erated and adjusted well to the examiner and the environment. All individuals who 
participated in the evaluations completed the assessments. 
Global cognitive abilities
LD was found in 95% of individuals with severe congenital, 83% with mild con-
genital and 89% of those with childhood DM1. For the six individuals who could 
not complete any psychometric assessment, the level of LD was based on the mean 
�ABS. No significant differences regarding mean FSIQ were found between males 
and females in the different DM1 subgroups. No significant correlations were found 
between FSIQ and gross motor function. 
�erbal IQ (�IQ) and Performance IQ (PIQ) were assessed in 37 individuals using 
the Wechsler scales. �IQ was significantly higher than PIQ in severe congenital and 
childhood DM1. There were no gender differences with respect to �IQ and PIQ in 
any subgroup.
Adaptive behaviour 
On the �ABS scores, almost all the participants scored below the standard scores 
and adequate level matching their age. Where a psychometric assessment was per-
formed, a significant correlation was found between the mean �ABS score and FSIQ 
in mild congenital and childhood DM1. In general, the individuals performed bet-
ter in the Socialisation domain, compared with the other domains. Mean �ABS 
scores did not relate to gender or motor function in any DM1 subgroup.
Study IV
Visual acuity
Six individuals from the total cohort had �I (12 %) and 19 individuals had subnor-
mal �A.
Only 48% of the individuals with DM1 > 4 years of age had BC�A ≥ 0.8 (including 
two individuals assessed with Cardiff cards), compared with 100% of the controls. 
Best corrected visual acuity (BC�A) in the different subgroups and the controls are 
presented in Figure 9.
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Neither significant refractive error, nor fundus pathology affected visual acuity. Of 
the six individuals with �I, five were males with severe congenital DM1 and one 
a girl with mild congenital DM1. All but two with �I  had a significant refractive 
error, three with hyperopia ≥ 4 D SE, one with hyperopia ≥ 2 D SE alone and two 
with astigmatism in combination with hyperopia ≥ 4 D SE. Four individuals had 
ASC, and all had LD.
Figure 9 BCVA in the different subgroups of DM1 and the control groups
Box-plot values for best corrected visual acuity (BCVA) in the DM1 subgroups and the 
control groups. The boxes show the median (line), mean (small white squares) and 25th 
and 75th percentiles. The whiskers show the 5th and 95th percentiles and x the 1th and 99th 
percentiles.
Refractive error
Thirty-three (67%) of the individuals with DM1 had significant refractive errors. 
The individuals in the three DM1 subgroups had significantly more refractive errors 
than the controls.
Hyperopia ≥2 D SE was found in 27 (55%) of all individuals with DM1 and 19 
(39%) of these individuals had hyperopia ≥4 D SE. Both hyperopia ≥2 and ≥4 D 
SE was significantly more prevalent in all the DM1 subgroups than in the control 
group. Hyperopia ≥4 D SE was significantly more prevalent in those with �I com-
pared with those without. The individuals in the three DM1 subgroups were signifi-
cantly more astigmatic than their controls.
Lens and fundus abnormalities
No true cataract was found in the whole study group; however, the most common 
finding was bilateral subtle haze or condensation in the posterior lens pole, found in 
39% of the individuals.
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�arious scattered changes, such as tortuous vessels, indistinct foveal reflex and mi-
nor changes of the optic disc were found on fundus examination, but no pathologi-
cal pigmentation.
VEP abnormalities
Nine individuals had abnormal �EPs; i.e., late P1 latencies or side difference to mon-
ocular stimulation.
One adolescent with severe congenital DM1 presented with late N1 (90 ms) in com-
bination with late P1 and subnormal vision.  Four children in the congenital sub-
groups had normal N1 but late P1. 10.5 % of the study assessed with �EP had side 
difference to monocular stimulation.
Correlation visual and cognitive function
There were correlations between BC�A and FSIQ; the lower the BC�A, the low-
er the FSIQ (in severe congenital: rs = 0.54, p=0.029; mild congenital rs = 0.62, 
p=0.025; childhood DM1: rs = 0.48, p=0.041). However, there was no correlation 
between BC�A and PIQ.
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Validity and reliability aspects
Isometric muscle strength
The dynomometer is a reliable method assessing muscle strength in children shown 
by several studies (Scott et al., 1982, Stuberg and Metcalf, 1988, Wadsworth et al., 
1987). The method has previously been shown to be reliable also for investigating 
individuals with LD (Surburg et al., 1992). In the present study several individu-
als had LD, and assessment of individuals with a developmental age younger than 
four years of age was difficult. The individuals with severe congenital DM1 had the 
greatest reduction in motor function, which may reflect most severe muscle strength 
impairment in this group. However, due to the high frequency of neuropsychiatric 
problems and the low cognitive level of the participants, few assessments of musle 
strength were obtained and comparison with the other subgroups was not possible.
Motor function
The HMA scale is a method for evaluation of muscle function in children with 
muscle disease based on typical development. However, motor function in healthy 
children has never been assessed using the scale and at what age the total score is 
achieved is unknown. Motor function in the individuals with DM1 was therefore 
compared with the results of a control group. Some items require a normal motor 
developmental age of approximately six years of age, confirmed by the performance 
of the healthy individuals in the control group. The HMA scale is primarily valid for 
detecting reduction in motor function in individuals with mild motor impairment, 
but less valid in individuals with severe reduction as they do not manage more than 
the first items in the test. 
ADI-R
This instrument has been shown to be valid and reliable in diagnosing autism and 
and in discriminating individuals with autism from individuals with LD when the 
non-verbal age is above 18 months (Hill et al., 2001, Lecavalier et al., 2006, Lord 
et al., 1997). By many, ADI-R is regarded as “the golden standard” in the diagnos-
tic procedure of autism. ADI-R has not been validated for autism in co-occurence 
with DM1, cranial nerve dysfunction or sensory impairments. In younger children, 
the instrument is less valid as poor agreement was found between the ADI-R and 
clinical judgment in children aged 14–25 months (Chawarska et al., 2007) and 
16–31 months (�entola et al., 2006). These results suggest that caution is warrant-
ed in interpreting the results of the ADI-R in very young children. In our study 
population, twelve out of 20 diagnosed individuals with AD fulfilled the ADI-R 
logarithm for the disorder. All of these individuals had a developmental age above 
18 months. The ADI-R interviews were all performed by the same clinical child 
psychologist. ADI-R was only one of the instruments used to collect information 
on autistic symptoms. ADI-R does not include an observation of the child. Aber-
rant personality traits and deficits in emotional recognition are described in adults 
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with DM1 (Delaporte, 1998, Winblad et al., 2005). Our impression was that the 
interviewed parents with DM1 tended to recognise and report too few symptoms 
and problems, which may contribute to explain the ADI-R results. For this reason, 
the diagnosis of ASC in children and adolescents with DM1 should not merely be 
based on the results of the ADI-R. 
Neuropsychiatric diagnostic procedure
The ASC diagnoses were made conjointly and based on all available information; 
personal examination (pediatric neurologist and clinical psychologist), joint analysis 
of the videotapes, interviews, questionnaires and checklists according to specific 
diagnostic criteria (DSM-I�, Gillberg and Gillberg criteria for AS).
Global cognitive assessment
Psychometric assessment was performed by the same child psychologist in the ma-
jority of the study population (84%). The Wechsler scales were a challenge to most 
of the participants. They cooperated and adjusted well to the examiner and the en-
vironment in spite of the fact that many of the individuals had ASC. All individuals 
who participated in the evaluations completed the assessments. 
The Griffiths Developmental Scale II is widely used in individuals with low devel-
opmental age, too young to be assessed with the Wechsler scales. Swedish norma-
tive data exist. According to one study, low scores on the language related scales at 
age 4 are correlated with moderate LD and behavioural problems at school (Conn, 
1993). Children with AD have been found to perform better on the performance 
subscales as opposed to verbal subscales on the Griffiths test (Sandberg et al., 1993). 
The Wechsler scales are widely used instruments for providing measures of global 
intellectual ability (FSIQ). Swedish normative data were used. The Wechsler scales 
are widely used instruments for providing measures of global intellectual ability 
(FSIQ). Swedish normative data were used. 
VABS
The �ABS have been reported to be a valid instrument in assessing the cognitive lev-
el in individuals with profound and severe LD (de Bildt et al., 2005). To date, there 
is no consensus on how to combine the social quotient (the social developmental 
level in relation to age obtained by the �ABS) and intellectual quotient (IQ obtained 
by psychometric assessment). Where a psychometric assessment was performed, a 
significant correlation was found between the mean �ABS score and FSIQ in mild 
congenital and childhood DM1. The individuals with DM1 scored lower regarding 
adaptive level as opposed to intellectual level on all DM1 forms. We therefore believe 
that the poor results on the Griffiths and Wechsler scales represent the true cognitive 
level of the individuals with DM1 in our study population. 
Visual function
�isual acuity testing requires intact recognition, visual memory as well as good co-
operation. The mode of assessment was adapted to developmental age and testability. 
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All ophthalmological and orthoptic assessments were performed by an experienced 
orthoptist and a paediatric ophthalmologist, the latter performing all the �EP ex-
aminations.
The �EP testing was performed as flash testing as assessment with pattern �EP re-
quires co-operation and stable fixation and many children were unable to participate 
properly. 
Representativeness of study groups
Our cohort of individuals with DM1 was recruited from paediatric rehabilitation 
centres in the western and southern health care regions of Sweden. Sweden has a 
well-developed health care system for children with motor disabilities with virtu-
ally no privat alternatives to the public health care system. As individuals with the 
congenital forms of DM1 have motor impairment, they are most likely detected and 
known by the rehabilitation centres. A large group of the identified individuals with 
the congenital forms were included in this study. The findings and conclusions re-
garding congenital DM1 are therefore regarded as representative and generalisable. 
Individuals with childhood DM1 are, however, an underrecognised group. As mo-
tor impairment is not a major problem, the individuals are often not known by the 
rehabilitation centres except for some individuals with LDs and speech problems. 
The individuals with childhood DM1 in our study could represent a more selected 
population with more pronounced impairment of motor and/or cognitive function, 
as opposed to the patients in other studies on childhood DM1 where the ndividuals 
were recruited from patient organisations or from paediatric genetic consultation 
clinics (Angeard et al., 2007, Steyaert et al., 1997). Most certainly there are undiag-
nosed individuals with childhood DM1 in the population in these two health care 
regions. The true frequency of childhood DM1 could only be ascertained by DNA 
analysis of all family members of known individuals with DM1, a procedure neither 
recommended nor ethical.
General discussion on major findings 
Classification and correlations between CTG repeat expansion size and clinical 
findings
This study describes a group of children and adolescents with congenital and child-
hood onset forms of DM1. Within the group of children with congenital DM1 there 
was great heterogeneity regarding clinical features and a decision was made to split 
the group. All individuals presented with symptoms in utero or from birth, but in 
addition the children with severe congenital DM1 had had a life-threatening condi-
tion at birth with need for resuscitation and/or respiratory assistance. 
The severe congenital form seemed to be a distinct group with clear diff erences com-
pared to the children with mild congenital DM1. There was a male preponderance 
and in all individuals the disorder was transmitted maternally. There was less dif-
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ference between the congenital groups with regard to the occurrence of ASC and 
age at independent walking. The phenotypic presentation regarding other variables 
varied less between the mild congenital and childhood DM1. Until recently, the 
presented classification had not been used in any previous study (Echenne et al., 
2008). Classifying DM1 into four different forms (congenital, childhood, classical 
and late onset) is not a clearcut distribution; rather, there is a continuum between 
the different forms. Even if I agree with the conclusion by Echenne that there is an 
overlap between the different subgroups, there are major clinical differences between 
the severe and mild congenital groups during the neonatal period and between the 
mild congenital and childhood DM1 during early infancy. The more severe the form 
of DM1, the lower the FSIQ, motor function and BC�A, and the higher the occur-
rence of ASC and �I. Further research is warranted regarding the prognostic value 
of these subgroups. 
The clinical picture showed great variability from one individual to another with the 
same CTG repeat expansion size. As an exemple, presence of expansion size by ap-
proximately 1000 expansions could be found in both the congenital as well as in the 
childhood DM1 subgroups. No clear phenotype-genotype correlations were found, 
even though the largest expansions were present in the severe congenital group. The 
CTG amplification had an impact on several parameters. The larger the amplifica-
tion, the more reduced the motor function, FSIQ, �IQ, PIQ, BC�A and �I. Due 
to somatic instability, the CTG expansion size increases with time in all categories 
of DM1, affecting several organ systems, and it would be reasonable to expect an 
impact on cognition related to the duration of the disorder.
Paternal inheritance was found in one fifth of the study population and this small 
group calls for caution when interpreting the results. It seems, however, that mater-
nal inheritance influences FSIQ, �IQ, PIQ and adaptation negatively. In the current 
study, the lower results on cognitive measurements found in individuals with mater-
nal inheritance in the childhood subgroup corroborates another study, and may be a 
reliable finding (Angeard et al., 2007)
  
Motor function 
The individuals with severe congenital DM1 had the most severely reduced motor 
function and the largest repeat expansions. The typical pattern of muscle weakness 
in DM1, with distal weakness being greater than proximal weakness was seen in 
most individuals in our study. However, the investigation revealed that the proxi-
mal muscles were also affected in many of the children, especially in those with the 
congenital onset form.
We have no information on the age at optimum motor function and time for dete-
rioration and muscle wasting in the study population, as the children have only been 
assessed once regarding muscle strength. To achieve such data, a prospective follow-
up study will have to be performed. However, few of the children had problems with 
walking, running or climbing stairs, although many were clumsy. Characteristic 
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compensatory manoeuvres due to muscle weakness were almost absent, but the chil-
dren moved slowly which could be compensate for the muscle weakness.  
Postural stability is the ability to maintain the body in equilibrium and requires 
information from the somatosensory, vestibular and visual systems. Activation of 
these systems induces postural reactions for the purpose of returning the body to 
equilibrium. To recover postural stability, the ankle joint movements are one of the 
essential strategies in sustained balance control and require intact range of move-
ments and strength in the ankles (Shumway-Cook and Woollacott, 1985). Many of 
the children with DM1 had problems with postural stability and control. The foot 
deformities, limited range of movements and weak ankle flexors present in many of 
the individuals with DM1 contributed to the effect on postural control and stabil-
ity. However, postural stability is well developed in other conditions with muscular 
weakness, such as spinal muscular atrophy (SMA), amyoplasia and Duchenne mus-
cular dystrophy (Kroksmark, 2006). It seems that delayed psychomotor develop-
ment and LD, frequently present in our population, may have a great impact on the 
automatic postural control system, similar to that in children with Down syndrome 
(Shumway-Cook 1985). Affection of the central motor control system has been 
shown in one study on adults with DM1 where movement-related cortical potentials 
preceding voluntary movements were investigated and subclinical abnormalities in 
CNS functioning were found independently of muscle weakness (Mitsuoka et al., 
2003).
Motor function was affected by impaired postural stability, delayed motor develop-
ment and, most certainly, by muscle weakness as well. The presence of contractures 
further aggravates motor function as contractures both have an impact on postural 
stability and muscle weakness. A muscle that is already weak may be further com-
promised if held in a shortened position (Eagle, 2002).  Although delayed walking 
ability in children with congenital DM1 and talipes by 14 months have been shown 
earlier (Roig et al., 1994), this finding was not confirmed in the present study as 
presence of foot deformities during the neonatal period in individuals in the con-
genital subgroups did not affect age at walking.
The excessive fatigue and day-time sleepiness seen in children and adolescents with 
DM1 is a prominent feature and most likely primarily due to affection of the CNS, 
although muscle weakness may aggravate the symptoms.The knowledge oo the high 
frequency of fatigue and day-time somnolence in our study was gained by reports 
from caregivers. No instrument measuring these problems was included in the study; 
hence, there was no information on muscle weakness being responsible for the pres-
ence of fatigue or somnolence.
Neuropsychiatry with special reference to ASC 
ASC and/or other neuropsychiatric disorders, such as ADHD and Tourette’s disor-
der, were found in 54% of the total DM1 group. Forty-nine per cent had ASC and 
AD was the most common diagnosis, present in 35% of the individuals. The indi-
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viduals with DM1 and ASC mainly had impairment in social interaction and com-
munication and, to a lesser degree, problems in the area of restricted repetitive and 
stereotyped patterns of behaviour, interests and activities, but enough to fulfil the 
criteria for ASC. In the current study, most of the individuals with DM1 and ASC 
fit the description of the passive type of ASC delineated by Wing (Wing, 1997), with 
reduced spontaneous social interaction but passive acceptance of approaches from 
others. This phenotype may be less recognisable as a part of the ASC by parents and 
clinicians and could be the reason why there are few reports on ASC in DM1 in the 
literature. There may be a risk of interpreting the passiveness as inattention and not 
as a part of the ASC symptomatology. 
In ASC, repetitive behaviour and stereotypies are common in addition to self-injuri-
ous behavior (Billstedt et al., 2005, Nordin and Gillberg, 1998). In our group, how-
ever, none of the individuals exhibited self-destructive behaviour. The behavioural 
phenotype of the individuals in our study population is further characterised by 
reduced initiative and slow pace, due, in part, both to fatigue and excessive day-time 
sleepiness. Day-time somnolence has been reported in childhood DM1 (Quera Salva 
et al., 2006), but not previously, to our knowledge, in individuals with congenital 
DM1. Day-time sleepiness has been found to be correlated with reduced size of the 
corpus callosum in adults with DM1 (Giubilei et al., 1999). In congenital DM1, 
MRI studies have shown corpus callosum hypoplasia (Hashimoto et al., 1995, Mar-
tinello et al., 1999), but whether such a correlation also exists between hypoplasia 
and excessive day-time sleepiness in our patients is unknown.
In several studies, children with ASC have been found to have reduced ability to 
recognise facial expressions of emotions (Celani et al., 1999, Hobson, 1986a, Hob-
son, 1986b), which, at least in part, accounts for the social disability in children with 
ASC (Frith, 1989). It has been argued that autistic symptoms in DM1 may be caused 
by difficulties in interpreting facial expressions secondary to poor non-verbal com-
munication in parents with DM1. In that case, the predominant autistic feature in 
children with DM1 would be difficulties with reciprocal communication. However, 
according to the results on the ADI-R, the problems pertaining to reciprocal com-
munication did not specifically exceed symptoms in other areas. 
The high rate of ADHD in childhood DM1 reported in another study (Goossens 
et al., 2000) could not be confirmed in the present study. Factors contributing to 
the discrepancy could be a referral bias or different assessment tools. In the present 
study, we used the DSM-I� checklist as well as the FTF to assign ADHD diagnoses. 
In adult DM1, attention deficits are also present (Modoni et al., 2004, Winblad et 
al., 2006b).
Behaviour abnormalities seem to be a constant feature in childhood and adult vari-
ants of DM1 with many symptoms in common. Studies on adult DM1 regard-
ing personality have shown an avoidant personality profile in approximately 20%. 
Reduced empathy and cooperativeness have also been observed (Delaporte, 1998, 
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Winblad et al., 2005). Furthermore, lack of social cognitive ability with failure in 
the ability to recognise facial emotions such as anger, fear and disgust has been 
found in a study on individuals with adult DM1 (Winblad et al., 2006a). The extent 
of inability was associated with the CTG repeat expansions size. Other studies on 
adult individuals with DM1 have used the Temperament and Character Inventory 
(TCI) pertaining to personality traits. High scores on Harm Avoidance (HA) and 
low scores on Persistence (PE) and Cooperativeness (CO) were identified (Meola et 
al., 2003, Winblad et al., 2005). A similar TCI profile with high scores on HA and 
low scores on CO have also been reported in adult patients with ASC (Anckarsater 
et al., 2006). Since one of the diagnostic criteria for AD is evidence of delayed or 
deviant development before 36 months of age, individuals with adult onset DM1 
cannot fulfill the criteria for AD. 
Emerging evidence of autism as a disorder affecting synaptic connections has re-
cently been presented (Garber, 2007). Inefficiently organised synaptic connections 
influence the formation of functional connectivity between different cortical re-
gions. Synapse-specific local protein synthesis is thought to be crucial for neurode-
velopment and plasticity and involves neuronal RNA-binding proteins. As described 
earlier, it would be reasonable to assume that both sliceopathy of Tau, NMDAR1 
and APP, as well as impaired transcription of DMWD, will have an impact on syn-
aptogenesis and accordingly development of autistic symtoms in DM1.
Cognitive and adaptive skills
LD was found in 95% per cent of those with severe congenital, 83% of those with 
mild congenital and 89% of those with childhood DM1. These results are in accord-
ance with the only other study using the same classification of the congenital groups 
as our study (Echenne et al., 2008). The individuals with childhood DM1, however, 
presented lower results than two other studies with a reasonably large sample of 
childhood DM1 patients (Angeard et al., 2007, Steyaert et al., 1997). Interestingly, 
in the childhood and mild congenital subgroups, individuals with paternal inherit-
ance had higher scores than individuals with maternal inheritance on the Wechsler 
subscales.   
   
The significant difference of a stronger �IQ than PIQ in childhood DM1 group 
corroborates another study on childhood DM1 (Angeard et al., 2007). �isuoper-
ceptual deficits are also present in adults (Winblad et al., 2006b). Low results on 
PIQ compared to �IQ are observed in several other syndromes and neurological 
disorders involving the central nervous system, including hydrocephalus (Lindquist 
et al., 2005), 22q11 deletion syndrome (Niklasson et al., 2005), and cerebral palsy 
(Carlsson et al., 1994). The relative strength in verbal compared to performance 
tasks in individuals with childhood DM1 group is due to better verbal understand-
ing (�ocabulary and Similarities). The relatively high scores on the performance 
subtest Picture arrangement in childhood DM1 is probably explained by the verbal 
element in this task. According to the �ABS, impressive language exceeded expres-
sive language ability in all DM1 subgroups. 
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The poor results on the WISC-III/WAIS-III subtests in the congenital groups made 
it impossible to perform in-depth analyses of cognitive profiles in these groups. 
However, all groups seemed to show poor results on Arithmetic. In AD, selective 
impairment is seen in certain subtests (Picture Arrangement and Comprehension) 
and good performance in others (Block Design and Digit Span) (Happe, 1994). In 
childhood DM1, with better subtest results, the typical peaks and troughs described 
in AD were not found. On the other hand, the occurrence of AD was not as preva-
lent in this group.
Almost all participants showed poor results on the �ABS. Individuals with AD usu-
ally have higher scores on Communication and Daily Living than on Social skills 
on the �ABS (Kraijer, 2000). Even though the individuals in our study achieved 
the comparatively highest scores in the Socialisation domain, the results were gen-
erally low, as 94-100% of individuals with congenital and childhood DM1 scored 
less than adequate in the socialisation subdomain, indicating problems with social 
interaction. No difference regarding the �ABS profile was detected between the 
individuals with and without ASC, respectively. 
Visual function 
The size of the CTG repeat expansion had an impact on BC�A in all subgroups with 
lower values in individuals with larger expansion size. The CTG repeat expansion 
size affected the occurrence of high hyperopia and astigmatism negatively only in 
the childhood subgroup. �I was found in 12% of the total study population and all 
but one of these individuals were in the severe congenital DM1 group. Subnormal 
�A was found in 39% of the individuals, mainly in the congenital groups. Only 
18% of the individuals with severe congenital DM1 had normal �A. Hyperopia was 
found in 55% of all individuals with DM1 and 39% of them had high hyperopia 
(≥4 D SE). Hyperopia was significantly more prevalent in all the DM1 subgroups 
than in the control group and high hyperopia was significantly more prevalent in 
individuals with �I than in those without. 
The majority of infants are normally born with hyperopia. The process of emmet-
ropisation is partly due to visual feedback. Blurring of the retinal image due to 
strabismus, short axial length, corneal abnormalities and accommodative failure 
will all influence the process. Short axial length has been reported in children with 
DM1 (Weiss et al., 1989) and increased thickness of the cornea in adults (Rosa et 
al., 2008). Furthermore, if the afferent visual pathways are affected due to brain 
damage, the emmetropisation will be affected as well, with persistent hyperopia. 
Our findings of high hyperopia, astigmatism and �I in individuals with childhood 
DM1 may be suggestive not only of eye pathology but of CNS involvement also in 
this group.
This study included individuals with severe hyperopia without reduced BC�A, as 
well as individuals with severely reduced BC�A without refractive errors. Normal 
visual feedback could be assumed in individuals achieving normal �A with correc-
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tion, but in those individuals with reduced BC�A, abnormalities of the eye alone or 
in combination with CNS affection is present.
   
Affection of the lens would also affect visual feedback. In our population, however, 
manifest cataract was not present, although lens pathology suggestive of early stages 
of cataract was present in 41% of individuals. Preliminary data from our own mul-
tidisciplinary study show an increased prevalence of strabismus, especially esotropia, 
mainly of a partially accommodative type (Aring, forthcoming data).
The �EP assessment indicated normal primary visual pathways, i.e. normal N1 
potential and short latency activation of the primary visual cortex. However, im-
paired extrageniculate non-specific pathways or impaired central nervous impulse 
processing was present in 10 % similar to that found in children with progressive 
white matter abnormalities albeit to a lesser extent (Kristjansdottir et al., 2002). Just 
over 10% showed �EP findings with cortical side differences to monocular stimula-
tion, indicating abnormalities in the chiasma, as those found in albinism (Apkarian, 
1992) suggestive of a developmental anomaly. 
Evaluation using evoked potentials seems to be one way to elucidate the CNS in-
volvement in DM1. In adults with DM1, evidence of central involvement has also 
come from studies of brainstem auditory, somatosensory and visual evoked poten-
tials (Sandrini et al., 1986, Shaunak et al., 1999, �erhagen et al., 1992). Further-
more, electrophysiological alterations were not correlated either with subject age or 
disease duration (Cosi et al., 1992)
Regarding pathogenic mechanisms, mouse models have shown that enlarged CTG 
repeat expansions cause loss of function in the adjacent SIX5 gene due to epigenetic 
effects including methylation and chromatin condensation and result in progressive 
destruction of lens tissue and occurrence of cataract in mice (Klesert et al., 2000). 
However, decreased SIX5 transcription did not affect either corneal or retinal struc-
tures and/or function. 
Relation between visual impairment, cognition, ASC and motor function
A wide range of brain pathologies cause �I. Periventricular white matter lesions are 
the most common cause of cognitive visual dysfunction, mainly visual perceptual 
problems (Dutton 2001). Cognitive visual dysfunction includes other modalities as 
well, such as visuospatial and constructive abilities. Cognitive visual dysfunction 
in children have been described in several neurodevelopmental disorders and syn-
dromes such as CP (Stiers et al., 2002), hydrocephalus (Andersson et al., 2006), Wil-
liams syndrome (Farran and Jarrold, 2003), 22q11 (Zinkstok and van Amelsvoort, 
2005), and cerebral white matter disorders (Kristjansdottir et al., 2002).  
�I affects the quality of eye contact and also impacts on several aspects of develop-
ment of communication and social skills. Occurrence of visual perceptual problems 
is known to render difficulties in recognition of facial expressions. In individuals 
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with ASC, presence of visuospatial difficulties further aggravates their impairment.
Afferent visual information is processed in the occipital cortex. The information is 
then transferred to associative areas of the brain along the dorsal and the ventral 
streams (Dutton, 2003). The dorsal stream transfers information from the occipital 
cortex to the parietal and frontal cortex. The parietal lobe chooses which visual 
information to pay attention to and the information is passed on to the frontal 
lobes, which direct the head and eyes to look at the specific object. The motor cortex 
receives visual information and on basis of this information, movements are initi-
ated. The ventral stream, on the other hand, carries information to the temporal 
lobes. The temporal lobes are responsible for visual recognition, orientation and vi-
sual memory, among other functions (Dutton and Jacobson, 2001). Damage in the 
temporal area can result in impaired face recognition.  
In the current study, PIQ was lower than �IQ, but specific assessment of visual per-
ception was not performed.  It has been postulated that early brain damage may give 
rise to specific visual perceptual deficits, independently of - although occurring in 
association with - selective impairment of non-verbal intelligence (Stiers et al., 1999). 
As several brain abnormalities of developmental origin are known in at least con-
genital DM1, it would be more surprising if no cognitive visual dysfunction would 
be present. However, the low developmental age in many of the children with DM1 
makes assessment of visuoperceptual abilities a challenge. �isuoperceptual prob-
lems have been demonstrated in individuals with childhood DM1 with the poorest 
performance on tests measuring visuospatial construction ability (Object assembly 
and Block design) (Angeard et al., 2007). The same study demonstrated a negative 
correlation between CTG repeat expansion size and IQ measures but also a negative 
correlation between repeat size and measures of working memory and visuospatial 
skills, also in a context of normal or subnormal intelligence. The subtest profile in 
our population was in accordance with this study, with maternal inheritance result-
ing  in lower values than those obtained in individuals with paternally inherited 
disorder. Although the test results were poorer in our population compared to the 
French study. 
Eye motility problems are common in children with �I due to CNS affection such 
as strabismus, nystagmus, unstable fixation, inaccurate fast eye movements (dys-
metric saccades), and deficient smooth pursuit movements (Jacobson et al., 2002). 
Abnormal saccadic and smooth pursuit (SP) eye movements have an impact on vis-
uoperceptual ability. Abnormalities of saccadic eye movements have been described 
in adults with DM1 (Bollen et al., 1992, �erhagen et al., 1992, �ersino et al., 1998), 
as well as altered smooth pursuit (SP) eye movements (Anastasopoulos et al., 1996, 
Bollen et al., 1992, �erhagen et al., 1992, �ersino et al., 1998). No correlation of 
saccadic eye movement defects and severity of muscular affection or disease dura-
tion has been shown. Affection of saccadic eye movement may be attributable to 
CNS dysfunction (Di Costanzo et al., 1997). This statement is supported by the 
finding that low gain SP eye movement was unlikely to be related to extra-ocular 
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myopathy, but could rather be explained by periventricular white matter abnormali-
ties (Bollen et al., 1992). Furthermore, impairment of SP performance is related to 
both parieto-occipital and frontal white matter, the latter leading to the most severe 
SP impairment (Kimmig et al., 2002). Preliminary data from our own multidisci-
plinary study show abnormal horizontal SP, saccade abnormalities and nystagmus 
(Aring, forthcoming data).
�isual feedback is essential to remain postural stability. The refraction errors and 
low visual acuity as well as strabismus and altered eye-movements present in the 
study population will most certainly affect motor function, which may account for 
the reduced postural stability found in the individuals with DM1. Additionally, im-
paired processing of visual information will aggravate motor dysfunction further. 
Gender aspects
A preponderance of males in congenital DM1 was reported in 1984, but has not 
been mentioned or discussed since then (O’Brien and Harper, 1984). Evidence sug-
gests that females have an advantage over males, with a better outcome during the 
perinatal period, particularly after preterm birth (Di Renzo et al., 2007), and that 
male neonates are at greater risk of developing periventricular leukomalacia (P�L) 
than females (Hatzidaki et al., 2009). On the other hand, in Down syndrome mor-
tality is greater in females (Leonard et al., 2000). 
Our finding of a male preponderance in the severe congenital group may reflect the 
vulnerability of males. On the other hand, there is a possibility that females with se-
vere congenital DM1 are overrepresented as stillbirths in early pregnancy. Maternal 
inheritance was found in all individuals in the severe congenital group. In the mild 
congenital form, paternal inheritance was present in only three individuals, who had 
smaller CTG repeat expansions than the 13 individuals with maternal transmission. 
In childhood DM1, there was no significant difference in CTG repeat expansion 
size between individuals with maternal and paternal inheritance. 
The reported higher rate of ASC reported in males as opposed to females (Fom-
bonne, 2003) was not confirmed in our study, as no gender difference regarding 
ASC was present; nor were there any gender differences regarding FSIQ, �IQ or 
PIQ results. 
Strengths and limitations
Strengths
The current study provides data from a comparatively large group of young patients 
with congenital and childhood DM1. To our knowledge, this is the first study on 
childhood onset DM1 where motor function and isometric muscle strength, neu-
ropsychiatric disorders, adaptation and several visual parameters have been assessed 
systematically, and correlated with the size of the CTG repeat expansion. By com-
bining assessments of both global cognition and adaptation, the level of functioning 
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was more adequately described. The subgroups have been extensively examined in-
cluding complete molecular data on all individuals as well as their affected parent.
Limitations:
The lack of more suitable instruments for assessing the low levels of intellectual 
functioning is one limitation, but adding the �ABS to the test battery and the strong 
correlation between the �ABS and the intellectual level strengthen the results. No 
appropriate scales to quantify the degree of sleepiness were included in the test bat-
tery. 
The conjoint diagnostic procedure carries a potential risk of bias, and separate diag-
nostic assignment would have provided the possibility of analysing inter-rater real-
ibility, which was not the case in our study. 
No instrument based on interaction with and observation of the individuals in order 
to assess ASC was included. A valuable instrument would have been the Autism 
Diagnostic Observation Scale-Generic (ADOS-G) (Lord et al., 2000). In toddlers, 
good agreement has been found between the results on ADOS and the clinical di-
agnosis based on the DSM-I� criteria (�entola et al., 2006). A recently published 
study has also shown that a combination of ADI-R and ADOS provides important 
information in the diagnostic procedure of ASC in toddlers (Gray et al., 2008).  
Research implications
The results presented in this thesis are based on a cross-sectional study. Further stud-
ies are warranted to improve our understanding of several parameters. Prospective 
longitudinal follow-up studies will provide further knowledge on how age and the 
severity of the disorder influence the progress. 
A decline in intellectual functioning over time has been reported in individuals with 
childhood DM1 (Echenne et al., 2008, Steyaert et al., 1997). Due to somatic insta-
bility, the CTG expansion size will increase with time affecting different organs. To 
show a possible degenerative impact on several organ systems, including the brain 
and muscles, further research is needed. 
In-depth analyses of visuoperceptual deficits, as well as trials to examine whether the 
social deficits exhibited by children with DM1 include impairment of face recogni-
tion and emotion perception similar to the findings in adults with DM1, would be 
of great interest. 
As almost no ophthalmological studies on children with DM1 have been carried 
out, there is a need for further studies. Assessment of accommodation and saccadic 
eye movement are some parameters to be investigated, as the parents in our study 
reported a high prevalence of photosensitivity but no systematic investigation was 
performed. Investigation with electroretinography would also be of interest, as pho-
tosensitivity could be a symptom of retinal abnormalities. Retinal changes have not 
yet been described in children but are well known in adults with DM1 and may be 
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due, either to peripheral pigmentary degeneration similar to retinitis pigmentosa, or 
to a central macular lesion (Kimizuka et al., 1993).  
The impact of day-time sleepiness on cognitive abilities is still unclear, but has an 
influence on activities of daily life. Structured trials on different treatment modali-
ties are warranted. 
So far, no studies have been performed in children and adolescents with DM1 re-
garding the effect of muscle training. In adults, aerobic training has been shown to 
be safe and can improve fitness effectively and increase the muscle fibre diameter 
significantly without any creatine kinase increase (Orngreen et al., 2005). Whether 
any kind of systematic training of motor activity can postpone the noticed and ex-
pected deterioration of motor function is still unknown. It is possible to investigate 
both muscle strength and motor function in most of the children with DM1, which 
is a prerequisite for prospective longitudinal studies.
To elucidate what molecular events cause neuronal impairment in children with 
congenital and childhood forms of DM1, exploration of the correlation between 
brain imaging and molecular data with symptoms of ASC, LD and �I would be of 
great interest. Hopefully, further advances in the research into DM1 in children will 
shed light on the pathophysiology of ASC.
Further studies including MRI, PET and SPECT studies are warranted to elucidate 
what molecular events cause neuronal impairment with symptoms of ASC, LD and 
�I in children with congenital and childhood forms of DM1. Hopefully, further 
advances in the research concerning DM1 in children, will shed light on the patho-
physiology of ASC.
Finally, as molecularly based treatments targeting the RNA disease mechanism di-
rectly are being developed, further and closer collaboration between clinical and 
molecular-based research is required to evaluate the desirable reversal of the clinical 
features. Further research is required, hopefully making DM1 a treatable disorder 
in the future.
Clinical implications 
Although no trials on the effect of muscle training have been performed in children 
and adolescents with DM1, development of normal motor control and prophylactic 
chest care should be encouraged. Due to the risk of increasing contractures and 
skeletal deformities, regular follow-ups are recommended. 
Once muscle strength improves, LD and behavioural disturbances become the main 
clinical problems. LD and behavioural disturbances are the factors that have the 
greatest influence on the long-term management and prognosis of this cohort of 
individuals.
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The occurrence of ASC in almost half of the patients in our sample indicates that 
ASC is common in children and adolescents with DM1. Awareness of this comor-
bidity is crucial and may contribute to understand why patients with DM1 may not 
function as well as expected in their activities of daily life. Furthermore, knowledge 
of ASC is essential when planning the educational support and rehabilitation care 
for these patients. Occurrence of �I and limited facial expressions necessitate a va-
riety of autism diagnostic instruments in an effort to diagnose ASC in individuals 
with DM1; both interviews and observational instruments are needed. I believe that 
individuals with DM1, especially with the childhood onset form, will be discovered 
within the group of patients with unexplained ASC, LD and mild hypotonia. Early 
identification of ASC is of great clinical importance in order to instigate ameliora-
tive multimodal support and interventions.
It seems that the ASC in DM1 represent a unique phenotype and that the individu-
als are not as socially impaired as in “classic” autism. It should be emphasised that 
ASC represent a spectrum, and include a variety of conditions with different aetiol-
ogy; DM1 being one of these disorders with a complicated pathogenesis. There is 
no doubt, however, that cerebral involvement is a direct consequence of the genetic 
disorder. 
It is important to make an accurate neuropsychological assessment in children with 
DM1 to obtain information on the individual’s cognitive level and overall function-
ing, in order to improve school and everyday life functions. Awareness of ASC and 
LD comorbidity in DM1 is essential when planning the educational support and 
rehabilitation care provided to these patients.
An increased incidence of refractive errors, strabismus and visual impairment has 
a significant impact on visual function, which also influences neurodevelopmental 
and educational issues.
�isual impairment in individuals with congenital and childhood DM1 may be due 
to a combination of CNS abnormalities and focal changes in the eye. In clinical 
practice, individuals with DM1 are referred to ophthalmological assessment due to 
expected cataract, but this is true only for adult patients. Instead, the children and 
adolescents need early ophthalmological assessment and follow-up because of the 
variety of their visual function pathology, such as hyperopia, astigmatism and low 
�A. 
Early and careful assessment, taking into account both neurophthalmological and 
ophthalmological aspects, is essential for a correct diagnosis and the development of 
individualised rehabilitation programmes.
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Conclusions
DM1 in childhood shows a great variability with regard to symptoms and age at 
onset. Based on age at onset and presenting symptoms, the individuals were divided 
into severe and mild congenital, childhood and classical DM1.  At the individual 
level, the size of CTG repeat expansions cannot predict the DM1 form. No clear 
phenotype-genotype correlations were found even though the largest expansions 
were present in the severe congenital group.
Children with DM1 were significantly weaker than healthy controls in most of the 
assessed muscle groups but there was great variation regarding the degree of muscle 
weakness. Motor function was significantly reduced in children with DM1 com-
pared to healthy controls.
Almost half the study population had ASC and AD was the frequent ASC diagnosis. 
ASC did not predict the level of LD. Both conditions should be regarded as a con-
sequence of the disorder. 
In the present study, most of the children and adolescents with congenital and child-
hood DM1 had LD, usually in the moderate to severe range. Almost all the partici-
pants showed poor adaptive skills.
Compared with the controls, the children and adolescents showed a high prevalence 
of visual dysfunction with impact on the developing visual system, such as low visual 
acuity and refractive errors. No true cataract was found. Subtle non-specific fundus 
changes were present in addition to �EP pathology. In DM1, a variety of visual 
function pathologies are present with impact on the developing visual system.
 
The size of the CTG repeat expansion had an impact on several variables. The fre-
quency of ASC increased with increasing CTG repeat expansions. Motor function, 
FSIQ and BC�A and �ABS presented lower values in individuals with larger expan-
sion size. Maternal inheritance had a negative impact on intellectual and adaptive 
functioning. The more severe the form of DM1, the more reduced the motor func-
tion and BC�A and the higher the frequency of ASC and LD. 
In everyday life, it appears that individuals with DM1 primarily suffer from their 
CNS-related symptoms, such as cognitive deficits, day-time sleepiness, neuropsy-
chiatric problems and visual dysfunctions, rather than their neuromuscular symp-
toms. 
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Dystrofia myotonika typ 1 (DM1) orsakas av en instabil mutation (förstorad 
CTG repetition) på den långa armen av kromosom 19 (19q13). Sjukdomen är auto-
somalt dominant ärftlig vilket innebär att upprepningsrisken vid varje graviditet är 
50 %. Sjukdomen karakteriseras av att den tenderar att förvärras från generation till 
generation, vilket kallas anticipation. DM1 drabbar många olika organ och uppvisar 
varierande svårighetsgrad och ålder vid sjukdomsdebut. DM1 förekommer i fyra 
former: medfödd - (svår och mild), barndoms-, klassisk vuxen- och mild vuxenform. 
�id den medfödda formen ärvs sjukdomen i de allra flesta fall från mamman. Den 
medfödda formen av DM1 förekommer hos ca 5:100 000 barn, men förekomsten 
varierar mellan olika geografiska områden. Den medfödda formen debuterar under 
fosterlivet eller vid födelsen. Minskade fosterrörelser och överskott av fostervatten 
är symptomen under fosterlivet. �id födelsen uppvisar barnet en uttalad generell 
muskelslapphet inklusive ansiktssvaghet. Till följd av denna slapphet har barnet 
andnings- och sugsvårigheter samt leddeformiteter (tex klumpfot). �id både svår 
och mild medfödd form har barnet symptom från födelsen men skillnaden består 
i att den svåra formen innebär ett livshotande tillstånd vid födelsen med tecken 
på syrebrist och behov av andningsunderstöd. Hos barn med barndomsformen 
debuterar symptomen mellan 1 och 10 års ålder efter en okomplicerad graviditet 
och nyföddhetsperiod. Utvecklingen är normal under första levnadsåret, men under 
småbarnsåren förekommer tal- och inlärningssvårigheter, viss grad av nedsatt mus-
kelspänning, men muskelsymptomen är oftast diskreta. Myotoni (”muskelspasm”) 
debuterar oftast i skolåldern. Buksmärtor är ett vanligt förekommande symptom.
Denna avhandling presenterar resultaten från några av de delstudier som ingår 
i en multidisciplinär deskriptiv tvärsnittsstudie, ett samarbetsprojekt mellan Drott-
ning Silvias barn- och ungdomssjukhus, Göteborg, NU-sjukvården NÄL, Trollhät-
tan, Odontologen och Mun-H-Center, Göteborg, Barn- och ungdomshabiliteringar 
i �ästra Götaland, Skåne och Halland, samt Barn- och ungdomsklinikerna i Skåne 
och Halland.
Projektets målsättning har varit att undersöka problem och svårigheter hos barn med 
DM1. Resultaten skall untgöra ett underlag för att optimera vården och omhän-
dertagandet av barnen. 
Syftet med studien har varit att 1) beskriva den kliniska bilden under barn- och 
ungdomsåren, 2) att undersöka eventuell genotyp/fenotypkorrelation, d v s ta reda 
på om det fanns ett samband mellan antal repetitioner av CTG och symtombild, 4) 
beskriva motorisk förmåga och muskelfunktion, 5) undersöka kognitiva, adaptiva 
och neuropsykiatriska svårigheter samt 6) beskriva de syn- och ögonmässiga av-
vikelser som finns i gruppen. 
I de tre regionerna Skåne, Halland och �ästra Götaland inbjöds 64 barn och ung-
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domar med känd DM1 diagnos att delta i studien varav 59 tackade ja och ingick i 
studien, 20 hade svår medfödd-, 19 mild medfödd -, 19 
barndoms- och 2 hade klassisk form. 
I de metoder som användes ingick insamling av medicinsk information från jour-
naler. Sjukgymnast undersökte muskelstyrka, motorisk funktion och ledrörlighet. 
Muskelstyrka och motorisk förmåga jämfördes med värden hos barn i en kontroll-
grupp. Föräldrarna genomgick strukturerad intervju om svårigheter beträffande 
beteende, utveckling, och anpassning i vardagslivet ingick. Alla barn och ungdo-
mar bedömdes av psykolog avseende begåvningsnivå. Neuropsykiatriska diagnoser 
ställdes utifrån DSM-I�:s diagnoskriterier. Ögonläkare och ortoptist undersökte 
barnen med avseende på synskärpa, ögats brytningsförmåga, ögonbotten och lin-
sens utseende. Slutligen ingick en elektrofysiologisk undersökning av synbanorna. 
Resultaten jämfördes med värden hos barn i en kontrollgrupp. 
DM1 hos barn och ungdomar uppvisar stor variabilitet i symptom och debutålder. 
Antal CTG repetitioner kan ej på individnivå förutsäga sjukdomsformen, men de 
största repetitionerna återfinns i den svåra medfödda formen. I denna form var det 
en övervikt av pojkar och alla hade ärvt sjukdomen från sin mor.
Barn med den milda medfödda formen och barndomsformen är svagare än barn 
i kontrollgruppen i samtliga undersökta muskelgrupper. Barn med mild medfödd 
DM1 är svagare än barn med barndomsformen men det är stor variation vad gäller 
muskelstyrka. Kontrakturerna är vanligare vid undersökningstillfället än vid födels-
en. Särskilt fot- och ryggdeformiteter ökar med stigande ålder.
Knappt hälften av gruppen barn och ungdomar med DM1 har autismspektrum-
störning (ASC), men även andra neuropsykiatriska tillstånd förekommer. Det finns 
ingen koppling mellan förekomst av ASC och kön eller motorisk förmåga. Inte hel-
ler fanns det någon relation mellan begåvningsnivån och förekomsten av ASC, utan 
båda tillståndet är en konsekvens av sjukdomen. 
En övervägande majoritet av barnen och ungdomarna med dom medfödda former-
na och barndomsformen har utvecklingsstörning, oftast av måttlig eller svår grad. 
Nästan alla uppvisar dålig adaptiva förmåga, dvs nedsatt anpassningsförmåga gäl-
lande dagliga aktiviteter. 
Jämfört med friska kontroller har barn och ungdomar med DM1 en hög förekomst 
av ögon- och synförändringar till följd av bristande utveckling såsom låg synskärpa 
och brytningsfel. Många barn och ungdomar har linsförändringar. Därutöver finns 
varierande och ospecifika ögonbotten- och elektrofysiologiska förändringar. �id 
DM1 förekommer varierande avvikelser i synförmågan som i sin tur påverkar syn-
ens vidare utveckling. 
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Mutationens storlek påverkar sjukdomsbilden. Motorisk förmåga, begåvningsnivå, 
synskärpa och adaptiv förmåga är mer påverkade vid större mutation. Begåvning 
och adaptiv förmåga är lägre hos individer som har ärvt sjukdomen från modern 
jämfört med de som ärft sjukdomen från fadern. Ju svårare sjukdomsform desto 
sämre är motorisk förmåga och synskärpa. ASC och utvecklingsstörning är vanli-
gast vid den svåraste sjukdomsformen. 
I första hand påverkas vardagslivet hos individer med DM1 av de hjärnrelaterade 
symptomen såsom nedsatt begåvning, ne,ropsykiatriska svårigheter och synproblem. 
De neuromuskulära symptomen har inte lika stor betydelse för individens funktion 
i vardagen. 
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